+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Geography & Life Sciences: Chapter 58307

Chapter 58307 provides bibliographic information on scholary research in geography and in the life sciences.

Metrics and Epilepsy & Behavior. Epilepsy & Behavior 40c: 8-10

Metrics and statistics of frequency of occurrence of metamerism in consumer cameras for natural scenes. Journal of the Optical Society of America. A, Optics, Image Science, and Vision 32(7): 1390-1402

Metrics and tools for consistent cohort discovery and financial analyses post-transition to ICD-10-CM. Journal of the American Medical Informatics Association 22(3): 730-737

Metrics for Assessing the Quality of Groundwater Used for Public Supply, CA, USA: Equivalent-Population and Area. Environmental Science & Technology 49(14): 8330-8338

Metrics for Electronic-Nursing-Record-Based Narratives: cross-sectional analysis. Applied Clinical Informatics 7(4): 1107-1119

Metrics for Original Research Articles in the AJR: From First Submission to Final Publication. Ajr. American Journal of Roentgenology 204(6): 1152-1156

Metrics for Radiologists in the Era of Value-based Health Care Delivery. Radiographics 35(3): 866-876

Metrics for Success: Strategies for Enabling Core Facility Performance and Assessing Outcomes. Journal of Biomolecular Techniques 27(1): 25-39

Metrics for assessing cytoskeletal orientational correlations and consistency. Plos Computational Biology 11(4): E1004190-E1004190

Metrics for biogeophysical climate forcings from land use and land cover changes and their inclusion in life cycle assessment: a critical review. Environmental Science & Technology 49(6): 3291-3303

Metrics for evaluating 3D medical image segmentation: analysis, selection, and tool. Bmc Medical Imaging 15(): 29-29

Metrics for evaluating the quality of handovers. JAMA Internal Medicine 175(4): 654-655

Metrics for monitoring cancer inequities: residential segregation, the Index of Concentration at the Extremes (ICE), and breast cancer estrogen receptor status (USA, 1992-2012). Cancer Causes & Control 27(9): 1139-1151

Metrics for nurse managers. Nursing Management 46(3): 30-36

Metrics for rapid quality control in RNA structure probing experiments. Bioinformatics 32(23): 3575-3583

Metrics for the Human Proteome Project 2015: Progress on the Human Proteome and Guidelines for High-Confidence Protein Identification. Journal of Proteome Research 14(9): 3452-3460

Metrics for the Human Proteome Project 2016: Progress on Identifying and Characterizing the Human Proteome, Including Post-Translational Modifications. Journal of Proteome Research 15(11): 3951-3960

Metrics in Urban Health: Current Developments and Future Prospects. Annual Review of Public Health 37: 113-133

Metrics in academic profiles: a new addictive game for researchers?. Revista Espanola de Salud Publica 90(): E1-E5

Metrics matter for knowledge workers like us. Journal of Thoracic and Cardiovascular Surgery 152(3): 934-935

Metrics of Arterial Hyperoxia and Associated Outcomes in Critical Care. Critical Care Medicine (): -

Metrics of High-Density Lipoprotein Function and Hospital Mortality in Acute Heart Failure Patients. Plos One 11(6): E0157507-E0157507

Metrics of Justice. A Sundial's Nomological Figuration. Nuncius 30(1): 161-194

Metrics of Quality in Graduate Training. Behavior Analysis in Practice 8(2): 136-137

Metrics of quality care in veterans: correlation between primary-care performance measures and inappropriate myocardial perfusion imaging. Clinical Cardiology 38(4): 195-199

Metrics of separation performance in chromatography: Part 3: General separation performance of linear solvent strength gradient liquid chromatography. Journal of Chromatography. A 1413: 9-21

Metrics of stress: a challenge of post-modernity. Revista de Neurologia 61(12): 576-576

Metrics of success: Measuring impact of a departmental near-miss incident learning system. Practical Radiation Oncology 5(5): E409-E416

Metrics of the normal anterior sclera: imaging with optical coherence tomography. Graefe's Archive for Clinical and Experimental Ophthalmology 253(9): 1575-1580

Metrics should be a complement in research, not a substitute for human judgment. Bmj 354: I4929-I4929

Metrics, Metrics, Metrics. Journal of the American College of Radiology 13(6): 628-629

Metro maps of plant disease dynamics--automated mining of differences using hyperspectral images. Plos One 10(1): E0116902-E0116902

Metro nature, environmental health, and economic value. Environmental Health Perspectives 123(5): 390-398

Metro passenger behaviors and their relations to metro incident involvement. Accident; Analysis and Prevention 82: 90-100

Metro-FOLFIRI as first line chemotherapy in metastatic colorectal cancer (MCRC). Preliminary report of a phase II trial. Journal of Clinical Oncology 23(16_suppl): 3722-3722

MetroHealth Care Plus: Effects Of A Prepared Safety Net On Quality Of Care In A Medicaid Expansion Population. Health Affairs 34(7): 1121-1130

Metrocoris Mayr (Insecta: Hemiptera: Gerridae) of India with descriptions of five new species. Zootaxa 4178(2): 257-277

Metrological Investigation of the (6,5) Carbon Nanotube Absorption Cross Section. Journal of Physical Chemistry Letters 4(9): 1460-1464

Metrological Validation of a Measurement Procedure for the Characterization of a Biological Ultrasound Tissue-Mimicking Material. Ultrasound in Medicine & Biology 43(1): 323-331

Metrological analysis of a virtual flowmeter-based transducer for cryogenic helium. Review of Scientific Instruments 86(12): 125001-125001

Metrological approaches to organic chemical purity: primary reference materials for vitamin D metabolites. Analytical and Bioanalytical Chemistry 407(28): 8557-8569

Metrological challenges for measurements of key climatological observables, Part 4: Atmospheric relative humidity. Metrologia 53(1): R40-R59

Metrological challenges for measurements of key climatological observables: Oceanic salinity and pH, and atmospheric humidity. Part 1: Overview. Metrologia 53(1): R1-R11

Metrological tests of a 200 L calibration source for HPGE detector systems for assay of radioactive waste drums. Applied Radiation and Isotopes 109: 114-117

Metrology Standards for Quantitative Imaging Biomarkers. Radiology 277(3): 813-825

Metrology and Standards Needs for Some Categories of Medical Devices. Journal of Research of the National Institute of Standards and Technology 113(2): 121-129

Metrology for Radiological Early Warning Networks in Europe ("METROERM")-A Joint European Metrology Research Project. Health Physics 111(2): 100-105

Metrology for drug delivery. Biomedizinische Technik. Biomedical Engineering 60(4): 271-275

Metrology in medicine: from measurements to decision, with specific reference to anesthesia and intensive care. Anesthesia and Analgesia 120(1): 66-75

Metrology of electromagnetic static actuation of MEMS microbridge using atomic force microscopy. Micron 84: 1-6

Metrology research on biomedical engineering publications from China in recent years. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 31(6): 1342-1345

Metrology test object for dimensional verification in additive manufacturing of metals for biomedical applications. Proceedings of the Institution of Mechanical Engineers. Part H, Journal of Engineering in Medicine 229(1): 20-27

Metrology with PT-Symmetric Cavities: Enhanced Sensitivity near the PT-Phase Transition. Physical Review Letters 117(11): 110802-110802

Metrology with Unknown Detectors. Physical Review Letters 116(10): 100802-100802

Metronidazole CNS toxicity. Acta Neurologica Belgica 115(4): 709-710

Metronidazole Induced Encephalopathy. Journal of the Association of Physicians of India 64(11): 72-74

Metronidazole Metabolism in Neonates and the Interplay Between Ontogeny and Genetic Variation. Journal of Clinical Pharmacology: -

Metronidazole Toxicity in Cockayne Syndrome: A Case Series. Pediatrics 136(3): E706-E708

Metronidazole amino acidum natrium combined with radiation in the treatment of nasopharyngeal carcinoma: A meta-analysis based on randomized controlled trials. Journal of Cancer Research and Therapeutics 11 Suppl 2(): C222-C225

Metronidazole containing pyrazole derivatives potently inhibit tyrosyl-tRNA synthetase: design, synthesis, and biological evaluation. Chemical Biology & Drug Design 88(4): 592-598

Metronidazole encephalopathy: Uncommon reaction to a common drug. International Journal of Critical Illness and Injury Science 5(2): 123-124

Metronidazole for the treatment of vaginal infections. Expert Opinion on PharmacoTherapy 16(7): 1109-1115

Metronidazole hydrazone conjugates: Design, synthesis, antiamoebic and molecular docking studies. Bioorganic & Medicinal Chemistry Letters 25(17): 3545-3549

Metronidazole in conjunction with penicillin neither prevents recurrence nor enhances recovery from peritonsillar abscess when compared with penicillin alone: a prospective, double-blind, randomized, placebo-controlled trial. Journal of Antimicrobial ChemoTherapy 71(6): 1681-1687

Metronidazole in extemporaneous prescriptions. Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und Verwandte Gebiete 67(6): 503-506

Metronidazole induced encephalopathy with peripheral polyneuropathy in patient with spinal cord injury. Korean Journal of Spine 9(1): 44-48

Metronidazole pharmacokinetics during rapid growth in turkeys - relation to changes in haemodynamics and drug metabolism. Journal of Veterinary Pharmacology and Therapeutics 39(4): 373-380

Metronidazole reduces the expression of cytochrome P450 enzymes in HepaRG cells and cryopreserved human hepatocytes. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 45(5): 413-419

Metronidazole toxicity presenting with acute onset of aphasia and right sided weakness. Journal of Clinical Neuroscience 22(7): 1199-1200

Metronidazole- and carbapenem-resistant bacteroides thetaiotaomicron isolated in Rochester, Minnesota, in 2014. Antimicrobial Agents and ChemoTherapy 59(7): 4157-4161

Metronidazole-Induced Bullous Pemphigoid: A Case Report. Journal of Clinical and Diagnostic Research 9(12): Fd01-Fd03

Metronidazole-Induced Cerebellar Toxicity. Neurology International 8(1): 6365-6365

Metronidazole-Induced Encephalopathy during Brain Abscess Treatment:Two Case Reports. No Shinkei Geka. Neurological Surgery 43(10): 927-932

Metronidazole-Induced Encephalopathy in Alcoholic Liver Disease: A Diagnostic and Therapeutic Challenge. Journal of Emergency Medicine 51(4): E79-E83

Metronidazole-but not IL-10 or prednisolone-rescues Trichuris muris infected C57BL/6 IL-10 deficient mice from severe disease. Veterinary Parasitology 212(3-4): 239-252

Metronidazole-induced central and peripheral nervous system toxicity. Neurological Sciences 36(9): 1737-1739

Metronidazole-induced combined peripheral and central vestibulopathy. Journal of the Neurological Sciences 365: 31-33

Metronidazole-induced encephalopathy after prolonged metronidazole course for treatment of C. difficile colitis. Bmj Case Reports 2015: -

Metronidazole-induced encephalopathy with contrast enhancing lesions on MRI. Journal of the Neurological Sciences 352(1-2): 129-131

Metronidazole-induced encephalopathy: not always a reversible situation. Neurocritical Care 22(3): 429-436

Metronidazole-induced neurotoxicity presenting with sudden bilateral hearing loss, encephalopathy, and cerebellar dysfunction. European Journal of Clinical Pharmacology: -

Metronidazole-triazole conjugates: activity against Clostridium difficile and parasites. European Journal of Medicinal Chemistry 101: 96-102

Metronidazole: encephalopathy. Prescrire International 24(158): 71-71

Metronidazole: psychotic disorders added to French SPCs and patient information leaflets. Prescrire International 24(158): 71-71

Metronome Cueing of Walking Reduces Gait Variability after a Cerebellar Stroke. Frontiers in Neurology 7: 84-84

Metronomic Chemotherapy for Metastatic Breast Cancer - a Systematic Review of the Literature. Geburtshilfe und Frauenheilkunde 76(5): 525-534

Metronomic Chemotherapy for Myxosarcoma Treatment in a Kori Bustard (Ardeotis kori). Journal of Avian Medicine and Surgery 29(3): 210-215

Metronomic Chemotherapy--A New Path to Treat Advanced Non-small Cell Lung Cancer. Zhongguo Fei Ai Za Zhi 18(4): 232-239

Metronomic Doses of Temozolomide Enhance the Efficacy of Carbon Nanotube CpG Immunotherapy in an Invasive Glioma Model. Plos One 11(2): E0148139-E0148139

Metronomic S-1 chemotherapy plus transcatheter arterial chemoembolization (TACE): a promising treatment of hepatocellular carcinoma refractory to TACE. Journal of B.U.On. 21(4): 909-916

Metronomic S-1 dosing and thymidylate synthase silencing have synergistic antitumor efficacy in a colorectal cancer xenograft model. Cancer Letters (): -

Metronomic capecitabine as extended adjuvant chemotherapy in women with triple negative breast cancer. Hematology/Oncology and Stem Cell Therapy 8(1): 22-27

Metronomic capecitabine as second-line treatment in hepatocellular carcinoma after sorafenib failure. Digestive and Liver Disease 47(6): 518-522

Metronomic chemotherapy (MC) with irinotecan (CPT-11) in patients with diagnosis of metastatic colorectal cancer (MCRC): clinical and pharmacodynamic evaluation. Journal of Clinical Oncology 24(18_suppl): 13111-13111

Metronomic chemotherapy and nanocarrier platforms. Cancer Letters (): -

Metronomic chemotherapy and radiotherapy as salvage treatment in refractory or relapsed pediatric solid tumours. Current Oncology 23(3): E253-E259

Metronomic chemotherapy for advanced pleomorphic adenocarcinoma of the nasopharynx. Acta Otorrinolaringologica Espanola 67(3): 182-184

Metronomic chemotherapy for triple negative breast cancer?. Aging 8(4): 573-574

Metronomic chemotherapy from rationale to clinical studies: a dream or reality?. Critical Reviews in Oncology/Hematology 95(1): 46-61

Metronomic chemotherapy in anaplastic thyroid carcinoma: a potentially feasible alternative to therapeutic nihilism. Indian Journal of Palliative Care 21(2): 245-249

Metronomic chemotherapy in head and neck cancer. Cancer Letters (): -

Metronomic chemotherapy in platinum-insensitive failures and/or early failures postmultimodality management in oral cancers. Indian Journal of Medical and Paediatric Oncology 36(3): 161-165

Metronomic chemotherapy in the neoadjuvant setting: results of two parallel feasibility trials (TraQme and TAME) in patients with HER2+ and HER2- locally advanced breast cancer. Brazilian Journal of Medical and Biological Research 48(5): 479-485

Metronomic chemotherapy plus/minus antiinflammatory treatment in far-advanced melanoma: A randomized multi-institutional phase II trial. Journal of Clinical Oncology 23(16_suppl): 3139-3139

Metronomic chemotherapy prevents therapy-induced stromal activation and induction of tumor-initiating cells. Journal of Experimental Medicine 213(13): 2967-2988

Metronomic chemotherapy with 5-fluorouracil and cisplatin for inoperable malignant bowel obstruction because of peritoneal dissemination from gastric cancer. Current Oncology 23(3): E248-E252

Metronomic chemotherapy with capecitabine for metastatic colorectal cancer in very elderly patients. Korean Journal of Internal Medicine: -

Metronomic chemotherapy with daily low-dose temozolomide and celecoxib in elderly patients with newly diagnosed glioblastoma multiforme: a retrospective analysis. Journal of Neuro-Oncology 124(2): 265-273

Metronomic chemotherapy with oral vinorelbine (mVNR) and capecitabine (mCAPE) in advanced HER2-negative breast cancer patients: is it a way to optimize disease control? Final results of the VICTOR-2 study. Breast Cancer Research and Treatment 160(3): 501-509

Metronomic chemotherapy: an attractive alternative to maximum tolerated dose therapy that can activate anti-tumor immunity and minimize therapeutic resistance. Cancer Letters 358(2): 100-106

Metronomic cyclophosphamide activation of anti-tumor immunity: tumor model, mouse host, and drug schedule dependence of gene responses and their upstream regulators. Bmc Cancer 16: 623-623

Metronomic cyclophosphamide enhances HPV16E7 peptide vaccine induced antigen-specific and cytotoxic T-cell mediated antitumor immune response. Oncoimmunology 3(8): E953407-E953407

Metronomic cyclophosphamide eradicates large implanted GL261 gliomas by activating antitumor Cd8<sup>+</sup> T-cell responses and immune memory. Oncoimmunology 4(4): E1005521-E1005521

Metronomic cyclophosphamide regimen electively depletes CD4+ CD25+ regulatory T cells in patients with advanced solid tumors. Journal of Clinical Oncology 24(18_suppl): 2561-2561

Metronomic cyclophosphamide therapy in hormone-naive patients with non-metastatic biochemical recurrent prostate cancer: a phase II trial. Medical Oncology 33(8): 89-89

Metronomic cyclophosphamide with bevacizumab provides disease stabilization in patients with advanced uterine cancer. Gynecologic Oncology Reports 12: 23-26

Metronomic methotrexate and cyclophosphamide after carboplatin included adjuvant chemotherapy in triple negative breast cancer: a phase III study. Annals of Translational Medicine 3(19): 284-284

Metronomic oral chemotherapy with old agents in patients with heavily treated metastatic breast cancer. Journal of Cancer Research and Therapeutics 11(2): 287-290

Metronomic oral cyclophosphamide (MOC) in the salvage therapy of heavily treated recurrent ovarian cancer patients: a retrospective, multicenter study. Bmc Cancer 14(): 947-947

Metronomic oral cyclophosphamide plus prednisone in docetaxel-pretreated patients with metastatic castration-resistant prostate cancer. Medical Oncology 32(1): 443-443

Metronomic oral vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer: results of a phase II trial (MOVE trial). Bmc Cancer 15(): 359-359

Metronomic oral vinorelbine in advanced breast cancer and non-small-cell lung cancer: current status and future development. Future Oncology 12(3): 373-387

Metronomic palliative chemotherapy in maxillary sinus tumor. South Asian Journal of Cancer 5(2): 56-58

Metronomic reloaded: Theoretical models bringing chemotherapy into the era of precision medicine. Seminars in Cancer Biology 35: 53-61

Metronomic temozolomide as second line treatment for metastatic poorly differentiated pancreatic neuroendocrine carcinoma. Journal of Translational Medicine 14(1): 113-113

Metronomic therapy can increase quality of life during paediatric palliative cancer care, but careful patient selection is essential. Acta Paediatrica 105(8): 946-951

Metronomic therapy with oral 6-mercaptopurine in elderly acute myeloid leukemia: A prospective pilot study. South Asian Journal of Cancer 5(2): 70-72

Metronomic topotecan impedes tumor growth of MYCN-amplified neuroblastoma cells in vitro and in vivo by therapy induced senescence. Oncotarget 7(3): 3571-3586

Metronomic vinorelbine (oral) in combination with sorafenib in advanced non-small cell lung cancer. Lung Cancer 88(3): 289-296

Metronomic vinorelbine: Anti-angiogenic activity in vitro in normoxic and severe hypoxic conditions, and severe hypoxia-induced resistance to its anti-proliferative effect with reversal by Akt inhibition. International Journal of Oncology 47(2): 455-464

Metronomics during palliative care in paediatric oncology? For sure! But handle me with care. Acta Paediatrica 105(8): 874-875

Metronomics for thymic carcinoma. Ecancermedicalscience 8: 494-494

Metroplasty to treat chronic pelvic pain resulting from outflow tract müllerian anomalies. American Journal of Obstetrics and Gynecology 213(6): 871.E1-3

Metropolis Evaluation of the Hartree-Fock Exchange Energy. Journal of Chemical Theory and Computation 10(10): 4317-4323

Metropolis revisited: the evolving role of librarians in informatics education for the health professions. Journal of the Medical Library Association 103(1): 14-18

Metropolis-Hastings thermal state sampling for numerical simulations of Bose-Einstein condensates. Computer Physics Communications 185(7): 1926-1931

Metropolitan urban hotspots of chronic sleep deprivation: evidence from a community health survey in Gyeongbuk Province, South Korea. Geospatial Health 10(2): 382-382

Metschnikowia cf. typographi and other pathogens from the bark beetle Ips sexdentatus - Prevalence, histological and ultrastructural evidence, and molecular characterization. Journal of Invertebrate Pathology 143(): 69-78

Metschnikowia: half tetrads, a regicide and the fountain of youth. Yeast (): -

Metstatic papillary thyroid carcinoma to maxilla: a rare case. Quintessence International 46(5): 431-435

Metsulfuron-methyl-based herbicidal ionic liquids. Journal of Agricultural and Food Chemistry 63(13): 3357-3366

Metyrapone effect on gastroprotective action of corticotropin-releasing factor administered centrally against indomethacin-induced gastric injury. Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 100(12): 1421-1430

Metyrapone stimulation test to diagnose central adrenal insufficiency. Lancet. Diabetes & Endocrinology 3(6): 407-407

Metyrapone, an inhibitor of cytochrome oxidases, does not affect viability in a neuroblastoma cell model of bilirubin toxicity. Molecular Genetics and Metabolism Reports 1(): 197-202

Metzia parva, a new cyprinid species (Teleostei: Cypriniformes) from south China. Zootaxa 3962: 226-234

Metzl Responds. American Journal of Public Health 106(5): E15, E17-E15, E17

Meuwissen et al. on Genomic Selection. Genetics 203(1): 5-7

Mevalonate Biosynthesis Intermediates Are Key Regulators of Innate Immunity in Bovine Endometritis. Journal of Immunology 196(2): 823-831

Mevalonate Cascade and Neurodevelopmental and Neurodegenerative Diseases: Future Targets for Therapeutic Application. Current Molecular Pharmacology (): -

Mevalonate Cascade and small Rho GTPase in Spinal Cord Injury. Current Molecular Pharmacology (): -

Mevalonate Pathway Antagonist Suppresses Formation of Serous Tubal Intraepithelial Carcinoma and Ovarian Carcinoma in Mouse Models. Clinical Cancer Research 21(20): 4652-4662

Mevalonate Pathway Blockade, Mitochondrial Dysfunction and Autophagy: A Possible Link. International Journal of Molecular Sciences 16(7): 16067-16084

Mevalonate Pathway Regulates Cell Size Homeostasis and Proteostasis through Autophagy. Cell Reports 13(11): 2610-2620

Mevalonate Pathway and Human Cancers. Current Molecular Pharmacology (): -

Mevalonate cascade and its regulation in cholesterol metabolism in different tissue in health and disease. Current Molecular Pharmacology (): -

Mevalonate inhibits acid sphingomyelinase activity, increases sphingomyelin levels and inhibits cell proliferation of HepG2 and Caco-2 cells. Lipids in Health and Disease 14(): 130-130

Mevalonate kinase deficiency (hyper-IgD syndrome) overlap mutation familial Mediterranean fever. Reumatologia Clinica: -

Mevalonate kinase deficiency in 2016. La Revue de Medecine Interne (): -

Mevalonate kinase deficiency: current perspectives. Application of Clinical Genetics 9: 101-110

Mevalonate-Farnesal Biosynthesis in Ticks: Comparative Synganglion Transcriptomics and a New Perspective. Plos One 11(3): E0141084-E0141084

Mevalonates restore zoledronic acid-induced osteoclastogenesis inhibition. Journal of Dental Research 94(4): 594-601

Mevalonosomes: specific vacuoles containing the mevalonate pathway in Plocamium brasiliense cortical cells (Rhodophyta). Journal of Phycology 51(2): 225-235

Mevastatin ameliorates sphingosine 1-phosphate-induced COX-2/PGE2-dependent cell migration via FoxO1 and CREB phosphorylation and translocation. British Journal of Pharmacology 172(22): 5360-5376

Mevastatin suppresses melanogenesis by lowering the levels of cyclic adenosine monophosphate and cholesterol. Experimental Dermatology 25(10): 820-822

Mexazolam: clinical efficacy and tolerability in the treatment of anxiety. Neurology and Therapy 3(1): 1-14

Mexiare gen. nov., a new Doryctinae genus (Hymenoptera: Braconidae) from Mexico with fused first and second metasomal tergites. Zootaxa 3914(2): 122-130

Mexican American adolescent couples' vulnerability for observed negativity and physical violence: Pregnancy and acculturation mismatch. Journal of Adolescence 52: 170-181

Mexican American adolescents' family obligation values and behaviors: links to internalizing symptoms across time and context. Developmental Psychology 51(1): 75-86

Mexican American women's perspectives on a culturally adapted cognitive-behavioral therapy guided self-help program for binge eating. Psychological Services 13(1): 31-41

Mexican Americans and historical trauma theory: a theoretical perspective. Journal of Ethnicity in Substance Abuse 8(3): 330-340

Mexican Americans are Less Likely to Return to Work Following Stroke: Clinical and Policy Implications. Journal of Stroke and Cerebrovascular Diseases 25(8): 1851-1855

Mexican Arnica (Heterotheca inuloides Cass. Asteraceae: Astereae): Ethnomedical uses, chemical constituents and biological properties. Journal of Ethnopharmacology (): -

Mexican Biosimilar Filgrastim for Autologous Hematopoietic Stem Cell Mobilization and Transplantation. Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 68(4): 181-183

Mexican Buprestidae: two new species of Acmaeodera Eschscholtz and a review of the genus Chalcophora Dejean. Zootaxa 3640: 572-580

Mexican Childhood Acute Lymphoblastic Leukemia: A Pilot Study of the MDR1 and MTHFR Gene Polymorphisms and Their Associations with Clinical Outcomes. Genetic Testing and Molecular Biomarkers 20(10): 597-602

Mexican Children under 2 Years of Age Consume Food Groups High in Energy and Low in Micronutrients. Journal of Nutrition 146(9): 1916s-1923s

Mexican Council of Orthopedics and Traumatology, A.C. Acta Ortopedica Mexicana 28(2): 75-76

Mexican Heritage Families in Transition and Youth Smoking Initiation. Journal of Adolescent Health 57(1): 3-4

Mexican Immigrant Health: Health Insurance Coverage Implications. Journal of Health Care for the Poor and Underserved 26(3): 990-1004

Mexican Men's View of Vasectomy. American Journal of Men's Health (): -

Mexican Regulation of Biobanks. Journal of Law, Medicine & Ethics 44(1): 58-67

Mexican Sobadores in North Carolina: Manual Therapy in a New Settlement Context. Journal of Immigrant and Minority Health (): -

Mexican Wolves Are a Valid Subspecies and an Appropriate Conservation Target. Journal of Heredity 106(4): 415-416

Mexican consensus on the diagnosis and management of hepatitis C infection. Annals of Hepatology 14 Suppl 1: 5-48

Mexican consensus on the diagnosis and management of hepatocellular carcinoma. Revista de Gastroenterologia de Mexico 79(4): 250-262

Mexican consumers' perceptions and attitudes towards farm animal welfare and willingness to pay for welfare friendly meat products. Meat Science 125(): 106-113

Mexican guidelines on the diagnosis and treatment of urticaria. Revista Alergia Mexico 61 Suppl 2: S118-S193

Mexican horse meat banned by EU. Journal of the American Veterinary Medical Association 246(4): 389-390

Mexican medicinal plants with anxiolytic or antidepressant activity: Focus on preclinical research. Journal of Ethnopharmacology 186(): 377-391

Mexican mothers' perceptions of their child's body weight. Health & Social Care in the Community (): -

Mexican propolis flavonoids affect photosynthesis and seedling growth. Journal of Photochemistry and Photobiology. B, Biology 151: 213-220

Mexican scientific production on influenza, 2000-2012. Salud Publica de Mexico 56(5): 424-425

Mexican species of the genus Exenterus Hartig (Hymenoptera: Ichneumonidae: Tryphoninae) reared from diprionid hosts. Zootaxa 4048(1): 140-150

Mexican unpasteurised fresh cheeses are contaminated with Salmonella spp., non-O157 Shiga toxin producing Escherichia coli and potential uropathogenic E. coli strains: A public health risk. International Journal of Food Microbiology 237(): 10-16

Mexican-American Adolescents' Gender-Typed Characteristics: The Role of Sibling and Friend Characteristics. Archives of Sexual Behavior 44(5): 1255-1268

Mexican-American caregivers' perceptions about asthma management: a photovoice study. Journal of Asthma 52(6): 593-599

Mexican-American perspectives on participation in clinical trials: A qualitative study. Contemporary Clinical Trials Communications 4(): 52-57

Mexican-Origin Youth Participation in Extracurricular Activities: Predicting Trajectories of Involvement from 7th to 12th Grade. Journal of Youth and Adolescence 44(11): 2172-2188

Mexican-origin parents' differential treatment and siblings' adjustment from adolescence to young adulthood. Journal of Family Psychology 43) 30(8): 955-965

Mexican-origin parents' work conditions and adolescents' adjustment. Journal of Family Psychology 43) 29(3): 447-457

Mexicanolide-Type Limonoids from the Roots of Trichilia sinensis. Molecules 21(9): -

Mexico City normal weight children exposed to high concentrations of ambient PM2.5 show high blood leptin and endothelin-1, vitamin D deficiency, and food reward hormone dysregulation versus low pollution controls. Relevance for obesity and Alzheimer disease. Environmental Research 140: 579-592

Mexico City's Petroleos Mexicanos explosion: disaster management and air medical transport. Air Medical Journal 33(6): 309-313

Mexico SimSmoke: how changes in tobacco control policies would impact smoking prevalence and smoking attributable deaths in Mexico. Global Public Health (): 1-16

Mexico keeps backing up with evidence its nutrition interventions. Salud Publica de Mexico 57(5): 368-371

Mexico struggles to keep foreign grants. Science 353(6295): 131-132

Mexico's Commitment to Global Health. Global Heart 11(4): 443-444

Mexico's Seguro Popular Appears To Have Helped Reduce The Risk Of Preterm Delivery Among Women With Low Education. Health Affairs 35(1): 80-87

Mexico's complex respiratory public health picture. Lancet. Respiratory Medicine 3(1): 18-19

Mexico's epidemic of violence and its public health significance on average length of life. Journal of Epidemiology and Community Health (): -

Mexico's path towards the Sustainable Development Goal for health: an assessment of the feasibility of reducing premature mortality by 40% by 2030. Lancet. Global Health 4(10): E714-E725

Mexidol in the rehabilitation of patients in the acute ischemic stroke. Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 115(12 Pt 2): 77-79

Mexiletine and its Interactions with Classical Antiepileptic Drugs: An Isobolographic Analysis. Neurochemical Research 41(5): 1185-1191

Mexiletine metabolites: a review. Current Medicinal Chemistry 22(11): 1400-1413

Mextli proteins use both canonical bipartite and novel tripartite binding modes to form eIF4E complexes that display differential sensitivity to 4E-BP regulation. Genes & Development 29(17): 1835-1849

Meyer dysplasia: a diagnosis to consider. Bmj Case Reports 2016: -

Meyer's Muscle Pedicle Bone Graft a Novel Procedure in Treatment of Neglected Fracture Neck of Femur in Pediatric Age Group-A Case Report. Journal of Clinical and Diagnostic Research 10(9): Rd03-Rd05

Meyer's loop asymmetry and language lateralisation in epilepsy. Journal of Neurology, Neurosurgery, and Psychiatry 87(8): 836-842

Meyer-Michel Samama, MD, PharmD (1927-2014). Seminars in Thrombosis and Hemostasis 40(8): 825-825

Meyerbeer, spa curist, biography of J. -F. Struensee, physician and man of the modernist state. Histoire des Sciences Medicales 49(2): 289-300

Meyerson Phenomenon as a Component of Melanoma in situ. Acta Dermatovenerologica Croatica 24(1): 81-82

Mfa4, an Accessory Protein of Mfa1 Fimbriae, Modulates Fimbrial Biogenesis, Cell Auto-Aggregation, and Biofilm Formation in Porphyromonas gingivalis. Plos One 10(10): E0139454-E0139454

Mfd Protein and Transcription-Repair Coupling in E. coli. Photochemistry and Photobiology (): -

Mfge8 regulates enterocyte lipid storage by promoting enterocyte triglyceride hydrolase activity. Jci Insight 1(18): E87418-E87418

Mfn1 Deficiency in the Liver Protects Against Diet-Induced Insulin Resistance and Enhances the Hypoglycemic Effect of Metformin. Diabetes 65(12): 3552-3560

Mfn2 Affects Embryo Development via Mitochondrial Dysfunction and Apoptosis. Plos One 10(5): E0125680-E0125680

Mfn2 deficiency links age-related sarcopenia and impaired autophagy to activation of an adaptive mitophagy pathway. Embo Journal 35(15): 1677-1693

Mfsd14a (Hiat1) gene disruption causes globozoospermia and infertility in male mice. Reproduction 152(1): 91-99

Mfsd2a Is a Transporter for the Essential ω-3 Fatty Acid Docosahexaenoic Acid (DHA) in Eye and Is Important for Photoreceptor Cell Development. Journal of Biological Chemistry 291(20): 10501-10514

Mfsd2a-based pharmacological strategies for drug delivery across the blood-brain barrier. Pharmacological Research 104: 124-131

Mg and Mg alloys: how comparable are in vitro and in vivo corrosion rates? A review. Acta Biomaterialia 13: 16-31

Mg chelatase in chlorophyll synthesis and retrograde signaling in Chlamydomonas reinhardtii: CHLI2 cannot substitute for CHLI1. Journal of Experimental Botany 67(13): 3925-3938

Mg deficiency affects leaf Mg remobilization and the proteome in Brassica napus. Plant Physiology and Biochemistry 107: 337-343

Mg intercalation in layered and spinel host crystal structures for Mg batteries. Inorganic Chemistry 54(9): 4394-4402

Mg substituted apatite coating from alkali conversion of acidic calcium phosphate. Materials Science & Engineering. C, Materials for Biological Applications 70(Pt 1): 408-417

Mg(++) requirement for MtHK binding, and Mg(++) stabilization of mitochondrial membranes via activation of MtHK & MtCK and promotion of mitochondrial permeability transition pore closure: A hypothesis on mechanisms underlying Mg(++)'s antioxidant and cytoprotective effects. Gene 581(1): 1-13

Mg(2+) differentially regulates two modes of mitochondrial Ca(2+) uptake in isolated cardiac mitochondria: implications for mitochondrial Ca(2+) sequestration. Journal of Bioenergetics and Biomembranes 48(3): 175-188

Mg(2+) shifts ligand-mediated folding of a riboswitch from induced-fit to conformational selection. Journal of the American Chemical Society 137(44): 14075-14083

Mg(2+)-Dependent Control of the Spatial Arrangement of Rhodococcus erythropolis PR4 Cells in Aqueous-Alkane Two Phase Culture Containing n-Dodecane. Microbes and Environments 31(2): 178-181

Mg(2+)-assisted low temperature reduction of alloyed AuPd/C: an efficient catalyst for hydrogen generation from formic acid at room temperature. Chemical Communications 51(54): 10887-10890

Mg(2+)-dependent facilitation and inactivation of L-type Ca(2+) channels in guinea pig ventricular myocytes. Journal of Pharmacological Sciences 129(3): 143-149

Mg(2+)/Ca(2+) promotes the adhesion of marine bacteria and algae and enhances following biofilm formation in artificial seawater. Colloids and Surfaces. B, Biointerfaces 146: 289-295

Mg(II) -Mediated Catalytic Asymmetric Dearomatization (CADA) Reaction of β-Naphthols with Dialkyl Acetylenedicarboxylates. Chemistry 22(25): 8483-8487

Mg(II) and Ni(II) induce aggregation of poly(rA)poly(rU) to either tetra-aggregate or triplex depending on the metal ion concentration. Journal of Inorganic Biochemistry 151: 115-122

Mg(II)-Catechin nanoparticles delivering siRNA targeting EIF5A2 inhibit bladder cancer cell growth in vitro and in vivo. Biomaterials 81: 125-134

Mg(OH)2 Supported Nanoscale Zero Valent Iron Enhancing the Removal of Pb(II) from Aqueous Solution. Acs Applied Materials & Interfaces 7(15): 7961-7969

Mg(PF6)2-Based Electrolyte Systems: Understanding Electrolyte-Electrode Interactions for the Development of Mg-Ion Batteries. Journal of the American Chemical Society 138(28): 8682-8685

Mg, Zn and Cu Transport Proteins: A Brief Overview from Physiological and Molecular Perspectives. Journal of Nutritional Science and Vitaminology 61 Suppl: S116-S118

Mg-Doped Hydroxyapatite/Chitosan Composite Coated 316L Stainless Steel Implants for Biomedical Applications. Journal of Nanoscience and Nanotechnology 15(6): 4178-4187

Mg-Enriched Engineered Carbon from Lithium-Ion Battery Anode for Phosphate Removal. Acs Applied Materials & Interfaces 8(5): 2905-2909

Mg-Prompted Polyfluoroarene C-H Functionalization: Formal Synthesis of Transfluthrin, Fenfluthrin, and Tefluthrin. Journal of Organic Chemistry 80(21): 10874-10882

Mg-Protoporphyrin IX Signals Enhance Plant's Tolerance to Cold Stress. Frontiers in Plant Science 7(): 1545-1545

Mg-Zr Cosubstituted Ta3N5 Photoanode for Lower-Onset-Potential Solar-Driven Photoelectrochemical Water Splitting. Journal of the American Chemical Society 137(40): 12780-3

Mg2+ Extrusion from Intestinal Epithelia by CNNM Proteins Is Essential for Gonadogenesis via AMPK-TORC1 Signaling in Caenorhabditis elegans. Plos Genetics 12(8): E1006276-E1006276

Mg2+ improves biomass production from soybean wastewater using purple non-sulfur bacteria. Journal of Environmental Sciences 28: 43-46

Mg2+ ions: do they bind to nucleobase nitrogens?. Nucleic Acids Research (): -

Mg2+ regulates transcription of mgtA in Salmonella Typhimurium via translation of proline codons during synthesis of the MgtL peptide. Proceedings of the National Academy of Sciences of the United States of America (): -

Mg2+, ATP-dependent plasma membrane calcium pump of smooth muscle cells. I. Structural organization and properties. Ukrainian Biochemical Journal 87(1): 5-20


Mg2+-dependent conformational changes and product release during DNA-catalyzed RNA ligation monitored by Bimane fluorescence. Nucleic Acids Research 43(1): 40-50

Mg2+/Mn2+-dependent phosphatase 1A is involved in regulating pregnane X receptor-mediated cytochrome p450 3A4 gene expression. Drug Metabolism and Disposition: the Biological Fate of Chemicals 43(3): 385-391

Mg3(VO4)2-MgO-ZrO2 nano-catalysts for oxidative dehydrogenation of n-butane. Journal of Nanoscience and Nanotechnology 14(11): 8879-8883

Mg<sup>II</sup> -Catalyzed Desymmetrization Reaction of meso-Aziridines with Hydroxylamines: Synthesis of Novel Chiral 1,2-Diamine Skeletons. Chemistry 22(48): 17141-17144

MgADP activation contributes to force enhancement during fast stretch of isolated skeletal myofibrils. Biochemical and Biophysical Research Communications 463(4): 1129-1134

MgAl- Layered Double Hydroxide Nanoparticles for controlled release of Salicylate. Materials Science & Engineering. C, Materials for Biological Applications 68: 557-564

MgF2-coated porous magnesium/alumina scaffolds with improved strength, corrosion resistance, and biological performance for biomedical applications. Materials Science & Engineering. C, Materials for Biological Applications 62: 634-642

MgI2 -mediated chemoselective cleavage of protecting groups: an alternative to conventional deprotection methodologies. Chemistry 21(31): 11014-6

MgI<sub>2</sub> -Chemoselective Cleavage for removal of amino acid protecting groups: A Fresh Vision for Peptide Synthesis. Biopolymers (): -

MgNd2 alloy in contact with nasal mucosa: an in vivo and in vitro approach. Journal of Materials Science. Materials in Medicine 27(2): 25-25

MgO-decorated few-layered graphene as an anode for li-ion batteries. Acs Applied Materials & Interfaces 7(4): 2301-2309

MgZnO Nanocrystals: Mechanism for Dopant-Stimulated Self-Assembly. Small 11(38): 5097-5104

Mga is essential for the survival of pluripotent cells during peri-implantation development. Development 142(1): 31-40

Mga2 Transcription Factor Regulates an Oxygen-responsive Lipid Homeostasis Pathway in Fission Yeast. Journal of Biological Chemistry 291(23): 12171-12183

Mga<i>Spn</i> and H-NS: Two Unrelated Global Regulators with Similar DNA-Binding Properties. Frontiers in Molecular Biosciences 3(): 60-60

Mgat5 modulates the effect of early life stress on adult behavior and physical health in mice. Behavioural Brain Research 312: 253-264

MgcRacGAP inhibition stimulates JAK-dependent STAT3 activity. Febs Letters 589(24 Pt B): 3859-3865

MgcRacGAP restricts active RhoA at the cytokinetic furrow and both RhoA and Rac1 at cell-cell junctions in epithelial cells. Molecular Biology of the Cell 26(13): 2439-2455

MglC, a Paralog of Myxococcus xanthus GTPase-Activating Protein MglB, Plays a Divergent Role in Motility Regulation. Journal of Bacteriology 198(3): 510-520

Mgm101: A double-duty Rad52-like protein. Cell Cycle 15(23): 3169-3176

Mgn-3/biobran enhances generation of cytotoxic CD8+ T cells via upregulation of dec-205 expression on dendritic cells. International Journal of Immunopathology and Pharmacology 27(4): 523-530

Mgr2 functions as lateral gatekeeper for preprotein sorting in the mitochondrial inner membrane. Molecular Cell 56(5): 641-652

MgrB mutations mediating polymyxin B resistance in Klebsiella pneumoniae isolates from rectal surveillance swabs in Brazil. Antimicrobial Agents and ChemoTherapy (): -

MgrB variants in colistin-susceptible and colistin-resistant Klebsiella pneumoniae ST258. Journal of Microbiology, Immunology, and Infection

MgtC as a Host-Induced Factor and Vaccine Candidate against Mycobacterium abscessus Infection. Infection and Immunity 84(10): 2895-2903

MgtE From Rhizobium leguminosarum Is a Mg²⁺ Channel Essential for Growth at Low pH and N2 Fixation on Specific Plants. Molecular Plant-Microbe Interactions 28(12): 1281-1287

MgxZn1-xO/Ag/MgxZn1-xO Multilayers As High-Performance Transparent Conductive Electrodes. Acs Applied Materials & Interfaces 8(3): 1565-1570

MhNCED3 in Malus hupehensis Rehd. induces NO generation under osmotic stress by regulating ABA accumulation. Plant Physiology and Biochemistry 96: 254-260

MhNCED3, a gene encoding 9-cis-epoxycarotenoid dioxygenase in Malus hupehensis Rehd., enhances plant tolerance to Cl- stress by reducing Cl- accumulation. Plant Physiology and Biochemistry 89: 85-91

Mhealth Intervention Development To Support Patients With Active Tuberculosis. Journal of Mobile Technology in Medicine 3(2): 16-27

Mi-1-Mediated Nematode Resistance in Tomatoes is Broken by Short-Term Heat Stress but Recovers Over Time. Journal of Nematology 47(2): 133-140

Mi-flp-18 and Mi-mpk-1 Genes are Potential Targets for Meloidogyne incognita Control. Journal of Parasitology 102(2): 208-213

MiBAlert-a new information tool to fight multidrug-resistant bacteria in the hospital setting. International Journal of Medical Informatics 95(): 43-48

MiDAS ENCORE: Randomized Controlled Clinical Trial Report of 6-Month Results. Pain Physician 19(2): 25-38

MiDAS ENCORE: Randomized Controlled Study Design and Protocol. Pain Physician 18(4): 307-316

MiDAS: the field guide to the microbes of activated sludge. Database 2015: Bav062-Bav062

MiFish, a set of universal PCR primers for metabarcoding environmental DNA from fishes: detection of more than 230 subtropical marine species. Royal Society Open Science 2(7): 150088-150088

MiL-FISH: Multilabeled Oligonucleotides for Fluorescence In Situ Hybridization Improve Visualization of Bacterial Cells. Applied and Environmental Microbiology 82(1): 62-70

MiOXSYS: a novel method of measuring oxidation reduction potential in semen and seminal plasma. Fertility and Sterility 106(3): 566-573.E10

MiR 20a,-20b and -200c are involved in hydrogen sulfide stimulation of VEGF production in human placental trophoblasts. Placenta 39(): 101-110

MiR 21-5p as a predictor of recurrence in young gastric cancer patients. Journal of Gastroenterology and Hepatology 31(8): 1429-1435

MiR 221/222 as new players in tamoxifen resistance. Current Pharmaceutical Design (): -

MiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis. Oncotarget 6(15): 13201-13215

MiR-100 Inhibits Osteosarcoma Cell Proliferation, Migration, and Invasion and Enhances Chemosensitivity by Targeting IGFIR. Technology in Cancer Research & Treatment 15(5): Np40-Np48

MiR-100-3p and miR-877-3p regulate overproduction of IL-8 and IL-1β in mesangial cells activated by secretory IgA from IgA nephropathy patients. Experimental Cell Research 347(2): 312-321

MiR-101 inhibits cell growth and tumorigenesis of Helicobacter pylori related gastric cancer by repression of SOCS2. Cancer Biology & Therapy 16(1): 160-169

MiR-101 reverses the hypomethylation of the LMO3 promoter in glioma cells. Oncotarget 6(10): 7930-7943

MiR-101 sensitizes human nasopharyngeal carcinoma cells to radiation by targeting stathmin 1. Molecular Medicine Reports 11(5): 3330-3336

MiR-101 targets DUSP1 to regulate the TGF-β secretion in sorafenib inhibits macrophage-induced growth of hepatocarcinoma. Oncotarget 6(21): 18389-18405

MiR-101 targets USP22 to inhibit the tumorigenesis of papillary thyroid carcinoma. American Journal of Cancer Research 6(11): 2575-2586

MiR-103 inhibits osteoblast proliferation mainly through suppressing Cav1.2 expression in simulated microgravity. Bone 76: 121-128

MiR-103 regulates hepatocellular carcinoma growth by targeting AKAP12. International Journal of Biochemistry & Cell Biology 71: 1-11

MiR-103a targeting Piezo1 is involved in acute myocardial infarction through regulating endothelium function. Cardiology Journal (): -

MiR-106a: Promising biomarker for cancer. Bioorganic & Medicinal Chemistry Letters (): -

MiR-106b exhibits an anti-angiogenic function by inhibiting STAT3 expression in endothelial cells. Lipids in Health and Disease 15(): 51-51

MiR-106b induces cell radioresistance via the PTEN/PI3K/AKT pathways and p21 in colorectal cancer. Journal of Translational Medicine 13(): 252-252

MiR-106b promotes migration and invasion through enhancing EMT via downregulation of Smad 7 in Kazakh's esophageal squamous cell carcinoma. Tumour Biology 37(11): 14595-14604

MiR-106b-5p Inhibits Tumor Necrosis Factor-α-induced Apoptosis by Targeting Phosphatase and Tensin Homolog Deleted on Chromosome 10 in Vascular Endothelial Cells. Chinese Medical Journal 129(12): 1406-1412

MiR-106b-mediated Mfn2 suppression is critical for PKM2 induced mitochondrial fusion. American Journal of Cancer Research 6(10): 2221-2234

MiR-106b~25 cluster regulates multidrug resistance in an ABC transporter-independent manner via downregulation of EP300. Oncology Reports 35(2): 1170-1178

MiR-107 down-regulates SIAH1 expression in human breast cancer cells and silencing of miR-107 inhibits tumor growth in a nude mouse model of triple-negative breast cancer. Molecular Carcinogenesis 55(5): 768-777

MiR-107 suppresses proliferation of hepatoma cells through targeting HMGA2 mRNA 3'UTR. Biochemical and Biophysical Research Communications 480(3): 455-460

MiR-10a and miR-181c regulate collagen type I generation in hypertrophic scars by targeting PAI-1 and uPA. Febs Letters 589(3): 380-389

MiR-10a improves hepatic fibrosis by regulating the TGFβl/Smads signal transduction pathway. Experimental and Therapeutic Medicine 12(3): 1719-1722

MiR-10b Directly Targets ZEB1 and PIK3CA to Curb Adenomyotic Epithelial Cell Invasiveness via Upregulation of E-Cadherin and Inhibition of Akt Phosphorylation. Cellular Physiology and Biochemistry 35(6): 2169-2180

MiR-10b decreases sensitivity of glioblastoma cells to radiation by targeting AKT. Journal of Biological Research 23(): 14-14

MiR-1178 promotes the proliferation, G1/S transition, migration and invasion of pancreatic cancer cells by targeting CHIP. Plos One 10(1): E0116934-E0116934

MiR-1180 promoted the proliferation of hepatocellular carcinoma cells by repressing TNIP2 expression. Biomedicine & PharmacoTherapy 79: 315-320

MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer. Cancer Letters 356(2 Pt B): 962-970

MiR-1188 at the imprinted Dlk1-Dio3 domain acts as a tumor suppressor in hepatoma cells. Molecular Biology of the Cell 26(8): 1416-1427

MiR-1193 suppresses proliferation and invasion of human breast cancer cells through directly targeting IGF2BP2. Oncology Research (): -

MiR-1204 sensitizes nasopharyngeal carcinoma cells to paclitaxel both in vitro and in vivo. Cancer Biology & Therapy 16(2): 261-267

MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway. Oncotarget 6(30): 28882-28894

MiR-122 Induces Radiosensitization in Non-Small Cell Lung Cancer Cell Line. International Journal of Molecular Sciences 16(9): 22137-22150

MiR-122 Reverses the Doxorubicin-Resistance in Hepatocellular Carcinoma Cells through Regulating the Tumor Metabolism. Plos One 11(5): E0152090-E0152090

MiR-122 in hepatitis B virus and hepatitis C virus dual infection. World Journal of Hepatology 7(3): 498-506

MiR-122 partly mediates the ochratoxin A-induced GC-2 cell apoptosis. Toxicology in Vitro 30(1 Pt B): 264-273

MiR-122 targets VEGFC in bladder cancer to inhibit tumor growth and angiogenesis. American Journal of Translational Research 8(7): 3056-3066

MiR-122 targets the vanin 1 gene to regulate its expression in chickens. Poultry Science 95(5): 1145-1150

MiR-1224-5p acts as a tumor suppressor by targeting CREB1 in malignant gliomas. Molecular and Cellular Biochemistry 403(1-2): 33-41

MiR-1228 promotes breast cancer cell growth and metastasis through targeting SCAI protein. International Journal of Clinical and Experimental Pathology 8(6): 6646-6655

MiR-124 Functions as a Tumor Suppressor via Targeting hCLOCK1 in Glioblastoma. Molecular Neurobiology (): -

MiR-124 Promote Neurogenic Transdifferentiation of Adipose Derived Mesenchymal Stromal Cells Partly through RhoA/ROCK1, but Not ROCK2 Signaling Pathway. Plos One 11(1): E0146646-E0146646

MiR-124 Promotes Newborn Olfactory Bulb Neuron Dendritic Morphogenesis and Spine Density. Journal of Molecular Neuroscience

MiR-124 Regulates Apoptosis and Autophagy Process in MPTP Model of Parkinson's Disease by Targeting to Bim. Brain Pathology 26(2): 167-176

MiR-124 effect in neurons apoptosis in newborn rat with thyroid hypofunction. International Journal of Clinical and Experimental Pathology 8(11): 14465-14471

MiR-124 exerts tumor suppressive functions on the cell proliferation, motility and angiogenesis of bladder cancer by fine-tuning UHRF1. Febs Journal 282(22): 4376-4388

MiR-124 inhibits cell proliferation in breast cancer through downregulation of CDK4. Tumour Biology 36(8): 5987-5997

MiR-124 inhibits cell proliferation, migration and invasion by directly targeting SOX9 in lung adenocarcinoma. Oncology Reports 35(5): 3115-3121

MiR-124 is differentially expressed in derivatives of the sympathoadrenal cell lineage and promotes neurite elongation in chromaffin cells. Cell and Tissue Research 365(2): 225-232

MiR-124 promotes bone marrow mesenchymal stem cells differentiation into neurogenic cells for accelerating recovery in the spinal cord injury. Tissue & Cell 47(2): 140-146

MiR-124 suppresses cell motility and adhesion by targeting talin 1 in prostate cancer cells. Cancer Cell International 15(): 49-49

MiR-124 suppresses the chemotactic migration of rat mesenchymal stem cells toward HGF by downregulating Wnt/β-catenin signaling. European Journal of Cell Biology 95(9): 342-353

MiR-124-3p/B4GALT1 axis plays an important role in SOCS3-regulated growth and chemo-sensitivity of CML. Journal of Hematology & Oncology 9(1): 69-69

MiR-1244 sensitizes the resistance of non-small cell lung cancer A549 cell to cisplatin. Cancer Cell International 16(): 30-30

MiR-1247-5p is overexpressed in castration resistant prostate cancer and targets MYCBP2. Prostate 75(8): 798-805

MiR-125a Rs12976445 Polymorphism is Associated with the Apoptosis Status of Nucleus Pulposus Cells and the Risk of Intervertebral Disc Degeneration. Cellular Physiology and Biochemistry 38(1): 295-305

MiR-125a regulates chemo-sensitivity to gemcitabine in human pancreatic cancer cells through targeting A20. Acta Biochimica et Biophysica Sinica 48(2): 202-208

MiR-125a regulates ovarian cancer proliferation and invasion by repressing GALNT14 expression. Biomedicine & PharmacoTherapy 80: 381-387

MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3. Oncotarget 6(28): 25266-25280

MiR-125a-3p regulates glioma apoptosis and invasion by regulating Nrg1. Plos One 10(1): E0116759-E0116759

MiR-125b Functions as a Tumor Suppressor and Enhances Chemosensitivity to Cisplatin in Osteosarcoma. Technology in Cancer Research & Treatment 15(6): Np105-Np112

MiR-125b Is Critical for Fibroblast-to-Myofibroblast Transition and Cardiac Fibrosis. Circulation 133(3): 291-301

MiR-125b Regulates Primordial Follicle Assembly by Targeting Activin Receptor Type 2a in Neonatal Mouse Ovary. Biology of Reproduction 94(4): 83-83

MiR-125b and miR-99a encoded on chromosome 21 co-regulate vincristine resistance in childhood acute megakaryoblastic leukemia. Hematology/Oncology and Stem Cell Therapy 8(2): 95-97

MiR-125b inhibits stromal cell proliferation in giant cell tumor of bone by targeting parathyroid hormone 1 receptor. Iranian Journal of Basic Medical Sciences 18(7): 705-709

MiR-125b protects against ethanol-induced apoptosis in neural crest cells and mouse embryos by targeting Bak 1 and PUMA. Experimental Neurology 271: 104-111

MiR-125b regulates SFRP5 expression to promote growth and activation of cardiac fibroblasts. Cell Biology International 40(11): 1224-1234

MiR-125b regulates epithelial-mesenchymal transition via targeting Sema4C in paclitaxel-resistant breast cancer cells. Oncotarget 6(5): 3268-3279

MiR-126 Contributes to Human Umbilical Cord Blood Cell-Induced Neurorestorative Effects After Stroke in Type-2 Diabetic Mice. Stem Cells 34(1): 102-113

MiR-126 Regulates the ERK Pathway via Targeting KRAS to Inhibit the Glioma Cell Proliferation and Invasion. Molecular Neurobiology (): -

MiR-126 Suppresses the Glucose-Stimulated Proliferation via IRS-2 in INS-1 β Cells. Plos One 11(2): E0149954-E0149954

MiR-126 inhibits vascular endothelial cell apoptosis through targeting PI3K/Akt signaling. Annals of Hematology 95(3): 365-374

MiR-126 regulated breast cancer cell invasion by targeting ADAM9. International Journal of Clinical and Experimental Pathology 8(6): 6547-6553

MiR-126 regulates proliferation and invasion in the bladder cancer BLS cell line by targeting the PIK3R2-mediated PI3K/Akt signaling pathway. Oncotargets and Therapy 9(): 5181-5193

MiR-127 modulates macrophage polarization and promotes lung inflammation and injury by activating the JNK pathway. Journal of Immunology 194(3): 1239-1251

MiR-1271 Inhibits Cell Proliferation, Invasion and EMT in Gastric Cancer by Targeting FOXQ1. Cellular Physiology and Biochemistry 36(4): 1382-1394

MiR-1271 Inhibits Ovarian Cancer Growth by Targeting Cyclin G1. Medical Science Monitor 21(): 3152-3158

MiR-1271 upregulated by saturated fatty acid palmitate provokes impaired insulin signaling by repressing INSR and IRS-1 expression in HepG2 cells. Biochemical and Biophysical Research Communications 478(4): 1786-1791

MiR-128 and miR-125 regulate expression of coagulation Factor IX gene with nonsense mutation by repressing nonsense-mediated mRNA decay. Biomedicine & PharmacoTherapy 80: 331-337

MiR-128 reverses the gefitinib resistance of the lung cancer stem cells by inhibiting the c-met/PI3K/AKT pathway. Oncotarget (): -

MiR-128, a key regulator of oncogenic properties. Molekuliarnaia Biologiia 49(1): 46-54

MiR-128-2 inhibits common lymphoid progenitors from developing into progenitor B cells. Oncotarget 7(14): 17520-17531

MiR-1284 modulates multidrug resistance of gastric cancer cells by targeting EIF4A1. Oncology Reports 35(5): 2583-2591

MiR-128b is down-regulated in gastric cancer and negatively regulates tumour cell viability by targeting PDK1/Akt/NF-κB axis. Journal of Biosciences 41(1): 77-85

MiR-129 regulates MMP9 to control metastasis of non-small cell lung cancer. Tumour Biology 36(8): 5785-5790

MiR-129 triggers autophagic flux by regulating a novel Notch-1/ E2F7/Beclin-1 axis to impair the viability of human malignant glioma cells. Oncotarget 7(8): 9222-9235

MiR-129-2 functions as a tumor suppressor in glioma cells by targeting HMGB1 and is down-regulated by DNA methylation. Molecular and Cellular Biochemistry 404(1-2): 229-239

MiR-129-5p is down-regulated and involved in migration and invasion of gastric cancer cells by targeting interleukin-8. Neoplasma 63(5): 673-680

MiR-129-5p is downregulated in breast cancer cells partly due to promoter H3K27m3 modification and regulates epithelial-mesenchymal transition and multi-drug resistance. European Review for Medical and Pharmacological Sciences 20(20): 4257-4265

MiR-129-5p-mediated Beclin-1 suppression inhibits endothelial cell autophagy in atherosclerosis. American Journal of Translational Research 8(4): 1886-1894

MiR-1290 promotes cancer progression by targeting nuclear factor I/X(NFIX) in esophageal squamous cell carcinoma (ESCC). Biomedicine & PharmacoTherapy 76: 82-93

MiR-1297 promotes apoptosis and inhibits the proliferation and invasion of hepatocellular carcinoma cells by targeting HMGA2. International Journal of Molecular Medicine 36(5): 1345-1352

MiR-1303 Regulates Mycobacteria Induced Autophagy by Targeting Atg2B. Plos One 11(1): E0146770-E0146770

MiR-130a and MiR-374a Function as Novel Regulators of Cisplatin Resistance in Human Ovarian Cancer A2780 Cells. Plos One 10(6): E0128886-E0128886

MiR-130a regulates neurite outgrowth and dendritic spine density by targeting MeCP2. Protein & Cell 7(7): 489-500

MiR-130a-3p regulates cell migration and invasion via inhibition of Smad4 in gemcitabine resistant hepatoma cells. Journal of Experimental & Clinical Cancer Research 35(): 19-19

MiR-130b inhibits proliferation and induces apoptosis of gastric cancer cells via CYLD. Tumour Biology 37(6): 7981-7987

MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells. Bmc Cancer 15(): 29-29

MiR-130b promotes obesity associated adipose tissue inflammation and insulin resistance in diabetes mice through alleviating M2 macrophage polarization via repression of PPAR-γ. Immunology Letters 180(): 1-8

MiR-132 Is Upregulated by Ischemic Preconditioning of Cultured Hippocampal Neurons and Protects them from Subsequent OGD Toxicity. Journal of Molecular Neuroscience 59(3): 404-410

MiR-132 Regulates Rem Expression in Cardiomyocytes During Long-Term β-Adrenoceptor Agonism. Cellular Physiology and Biochemistry 36(1): 141-154

MiR-132 inhibits cell proliferation, invasion and migration of hepatocellular carcinoma by targeting PIK3R3. International Journal of Oncology 47(4): 1585-1593

MiR-132 plays an oncogenic role in laryngeal squamous cell carcinoma by targeting FOXO1 and activating the PI3K/AKT pathway. European Journal of Pharmacology 792(): 1-6

MiR-132 prohibits proliferation, invasion, migration, and metastasis in breast cancer by targeting HN1. Biochemical and Biophysical Research Communications 454(1): 109-114

MiR-132 regulates osteogenic differentiation via downregulating Sirtuin1 in a peroxisome proliferator-activated receptor β/δ-dependent manner. Biochemical and Biophysical Research Communications 478(1): 260-267

MiR-132-3p Regulates the Osteogenic Differentiation of Thoracic Ligamentum Flavum Cells by Inhibiting Multiple Osteogenesis-Related Genes. International Journal of Molecular Sciences 17(8): -

MiR-133 is Involved in Estrogen Deficiency-Induced Osteoporosis through Modulating Osteogenic Differentiation of Mesenchymal Stem Cells. Medical Science Monitor 21(): 1527-1534

MiR-133 modulates TGF-β1-induced bladder smooth muscle cell hypertrophic and fibrotic response: implication for a role of microRNA in bladder wall remodeling caused by bladder outlet obstruction. Cellular Signalling 27(2): 215-227

MiR-133a Is Functionally Involved in Doxorubicin-Resistance in Breast Cancer Cells MCF-7 via Its Regulation of the Expression of Uncoupling Protein 2. Plos One 10(6): E0129843-E0129843

MiR-133a is downregulated in non-small cell lung cancer: a study of clinical significance. European Journal of Medical Research 20(): 50-50

MiR-133a regarded as a potential biomarker for benzene toxicity through targeting Caspase-9 to inhibit apoptosis induced by benzene metabolite (1,4-Benzoquinone). Science of the Total Environment 571: 883-891

MiR-133a suppresses the migration and invasion of esophageal cancer cells by targeting the EMT regulator SOX4. American Journal of Translational Research 7(8): 1390-1403

MiR-133b Promotes neurite outgrowth by targeting RhoA expression. Cellular Physiology and Biochemistry 35(1): 246-258

MiR-133b ameliorates axon degeneration induced by MPP(+) via targeting RhoA. Neuroscience 325: 39-49

MiR-133b inhibits growth of human gastric cancer cells by silencing PKM-splicer PTBP1. Cancer Science (): -

MiR-133b-5p regulates the expression of the heat shock protein 70 during rat neuronal cell apoptosis induced by the gp120 V3 loop peptide. Journal of Medical Virology 88(3): 437-447

MiR-134-Mbd3 axis regulates the induction of pluripotency. Journal of Cellular and Molecular Medicine 20(6): 1150-1158

MiR-135 post-transcriptionally regulates FOXO1 expression and promotes cell proliferation in human malignant melanoma cells. International Journal of Clinical and Experimental Pathology 8(6): 6356-6366

MiR-135a Suppresses Calcification in Senescent VSMCs by Regulating KLF4/STAT3 Pathway. Current Vascular Pharmacology 14(2): 211-218

MiR-135a and MRP1 play pivotal roles in the selective lethality of phenethyl isothiocyanate to malignant glioma cells. American Journal of Cancer Research 6(5): 957-972

MiR-135a inhibits migration and invasion and regulates EMT-related marker genes by targeting KLF8 in lung cancer cells. Biochemical and Biophysical Research Communications 465(1): 125-130

MiR-135b promotes proliferation of endometrial carcinoma cells by targeting FOXO1. Nan Fang Yi Ke Da Xue Xue Bao 36(5): 675-680

MiR-137 acts as a tumor suppressor in papillary thyroid carcinoma by targeting CXCL12. Oncology Reports 35(4): 2151-2158

MiR-137 affects melanin synthesis in mouse melanocyte by repressing the expression of c-Kit and Tyrp2 in SCF/c-Kit signaling pathway. Bioscience, Biotechnology, and Biochemistry (): 1-7

MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells. Journal of Experimental & Clinical Cancer Research 35(1): 132-132

MiR-137 inhibits proliferation and angiogenesis of human glioblastoma cells by targeting EZH2. Journal of Neuro-Oncology 122(3): 481-489

MiR-138 Acts as a Tumor Suppressor by Targeting EZH2 and Enhances Cisplatin-Induced Apoptosis in Osteosarcoma Cells. Plos One 11(3): E0150026-E0150026

MiR-138 Suppresses Cell Proliferation by Targeting Bag-1 in Gallbladder Carcinoma. Plos One 10(5): E0126499-E0126499

MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints. Neuro-Oncology 18(5): 639-648

MiR-138 inhibits cell proliferation and reverses epithelial-mesenchymal transition in non-small cell lung cancer cells by targeting GIT1 and SEMA4C. Journal of Cellular and Molecular Medicine 19(12): 2793-2805

MiR-138 promotes smooth muscle cells proliferation and migration in db/db mice through down-regulation of SIRT1. Biochemical and Biophysical Research Communications 463(4): 1159-1164

MiR-138 suppresses airway smooth muscle cell proliferation through the PI3K/AKT signaling pathway by targeting PDK1. Experimental Lung Research 41(7): 363-369

MiR-138-5p promotes TNF-α-induced apoptosis in human intervertebral disc degeneration by targeting SIRT1 through PTEN/PI3K/Akt signaling. Experimental Cell Research 345(2): 199-205

MiR-138/peroxisome proliferator-activated receptor β signaling regulates human hypertrophic scar fibroblast proliferation and movement in vitro. Journal of Dermatology 42(5): 485-495

MiR-139-3p induces cell apoptosis and inhibits metastasis of cervical cancer by targeting NOB1. Biomedicine & PharmacoTherapy 83(): 850-856

MiR-139-5p inhibits the biological function of breast cancer cells by targeting Notch1 and mediates chemosensitivity to docetaxel. Biochemical and Biophysical Research Communications 465(4): 702-713

MiR-139-5p is Increased in the Peripheral Blood of Patients with Prostate Cancer. Cellular Physiology and Biochemistry 39(3): 1111-1117

MiR-139-5p reverses CD44+/CD133+-associated multidrug resistance by downregulating NOTCH1 in colorectal carcinoma cells. Oncotarget (): -

MiR-139-5p: promising biomarker for cancer. Tumour Biology 36(3): 1355-1365

MiR-140-3p suppressed cell growth and invasion by downregulating the expression of ATP8A1 in non-small cell lung cancer . Tumour Biology 37(3): 2973-2985

MiR-140-5p regulates hypoxia-mediated human pulmonary artery smooth muscle cell proliferation, apoptosis and differentiation by targeting Dnmt1 and promoting SOD2 expression. Biochemical and Biophysical Research Communications 473(1): 342-348

MiR-141 Activates Nrf2-Dependent Antioxidant Pathway via Down-Regulating the Expression of Keap1 Conferring the Resistance of Hepatocellular Carcinoma Cells to 5-Fluorouracil. Cellular Physiology and Biochemistry 35(6): 2333-2348

MiR-141 Inhibits Gastric Cancer Proliferation by Interacting with Long Noncoding RNA MEG3 and Down-Regulating E2F3 Expression. Digestive Diseases and Sciences 60(11): 3271-3282

MiR-141-3p promotes prostate cancer cell proliferation through inhibiting kruppel-like factor-9 expression. Biochemical and Biophysical Research Communications (): -

MiR-142 acts as a tumor suppressor in osteosarcoma cell lines by targeting Rac1. Oncology Reports 33(3): 1291-1299

MiR-142 inhibits the development of cervical cancer by targeting HMGB1. Oncotarget (): -

MiR-142 is required for Staphylococcus aureus clearance at skin wound sites via small GTPase-mediated regulation of the neutrophil actin cytoskeleton. Journal of Investigative Dermatology (): -

MiR-142-3p Suppresses SOCS6 Expression and Promotes Cell Proliferation in Nasopharyngeal Carcinoma. Cellular Physiology and Biochemistry 36(5): 1743-1752

MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma. International Journal of Clinical and Experimental Pathology 8(9): 10800-7

MiR-142-5p and miR-486-5p as biomarkers for early detection of chronic antibody-mediated rejection in kidney transplantation. Biomarkers 1-10

MiR-142-5p promotes bone repair by maintaining osteoblast activity. Journal of Bone and Mineral Metabolism (): -

MiR-143 and MiR-145 regulate IGF1R to suppress cell proliferation in colorectal cancer. Plos One 9(12): E114420-E114420

MiR-143 and miR-135 inhibitors treatment induces skeletal myogenic differentiation of human adult dental pulp stem cells. Archives of Oral Biology 60(11): 1613-1617

MiR-143 and rat embryo implantation. Biochimica et Biophysica Acta 1850(4): 708-721

MiR-143 enhances the antitumor activity of shikonin by targeting BAG3 expression in human glioblastoma stem cells. Biochemical and Biophysical Research Communications 468(1-2): 105-112

MiR-143 inhibits tumor cell proliferation and invasion by targeting STAT3 in esophageal squamous cell carcinoma. Cancer Letters 373(1): 97-108

MiR-143 suppresses the epithelial-mesenchymal transition of spinal glioblastoma through down-regulation of ERK5. Oncotarget (): -

MiR-143 targets CTGF and exerts tumor-suppressing functions in epithelial ovarian cancer. American Journal of Translational Research 8(6): 2716-2726

MiR-143-3p controls TGF-β1-induced cell proliferation and extracellular matrix production in airway smooth muscle via negative regulation of the nuclear factor of activated T cells 1. Molecular Immunology 78(): 133-139

MiR-143-3p functions as a tumor suppressor by regulating cell proliferation, invasion and epithelial-mesenchymal transition by targeting QKI-5 in esophageal squamous cell carcinoma . Molecular Cancer 15(1): 51-51

MiR-144 Inhibits Uveal Melanoma Cell Proliferation and Invasion by Regulating c-Met Expression. Plos One 10(5): E0124428-E0124428

MiR-144 inhibits cell proliferation of renal cell carcinoma by targeting MTOR. Journal of Huazhong University of Science and Technology. Medical Sciences 36(2): 186-192

MiR-144 inhibits proliferation and induces apoptosis and autophagy in lung cancer cells by targeting TIGAR. Cellular Physiology and Biochemistry 35(3): 997-1007

MiR-144 suppresses cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting SMAD4. Oncotargets and Therapy 9(): 4705-4714

MiR-144-3p and Its Target Gene β-Amyloid Precursor Protein Regulate 1-Methyl-4-Phenyl-1,2-3,6-Tetrahydropyridine-Induced Mitochondrial Dysfunction. Molecules and Cells 39(7): 543-549

MiR-144-3p regulates osteogenic differentiation and proliferation of murine mesenchymal stem cells by specifically targeting Smad4. Febs Letters 590(6): 795-807

MiR-145 Regulates Lipogenesis in Goat Mammary Cells Via Targeting INSIG1 and Epigenetic Regulation of Lipid-Related Genes. Journal of Cellular Physiology (): -

MiR-145 acts as a metastasis suppressor by targeting metadherin in lung cancer. Medical Oncology 32(1): 344-344

MiR-145 and miR-203 represses TGF-β-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells. Lung Cancer 97(): 87-94

MiR-145 expression accelerates esophageal adenocarcinoma progression by enhancing cell invasion and anoikis resistance. Plos One 9(12): E115589-E115589

MiR-145 facilitates proliferation and migration of endothelial progenitor cells and recanalization of arterial thrombosis in cerebral infarction mice via JNK signal pathway. International Journal of Clinical and Experimental Pathology 8(10): 13770-6

MiR-145 functions as a tumor suppressor targeting NUAK1 in human intrahepatic cholangiocarcinoma. Biochemical and Biophysical Research Communications 465(2): 262-269

MiR-145 functions as a tumor suppressor via regulating angiopoietin-2 in pancreatic cancer cells. Cancer Cell International 16(1): 65-65

MiR-145 inhibits metastasis by targeting fascin actin-bundling protein 1 in nasopharyngeal carcinoma. Plos One 10(3): E0122228-E0122228

MiR-145 promotes TNF-α-induced apoptosis by facilitating the formation of RIP1-FADDcaspase-8 complex in triple-negative breast cancer. Tumour Biology 37(7): 8599-8607

MiR-145 suppressed human retinoblastoma cell proliferation and invasion by targeting ADAM19. International Journal of Clinical and Experimental Pathology 8(11): 14521-7

MiR-145 suppresses cell proliferation and motility by inhibiting ROCK1 in hepatocellular carcinoma. Tumour Biology 37(5): 6255-6260

MiR-145 suppresses embryo-epithelial juxtacrine communication at implantation by modulating maternal IGF1R. Journal of Cell Science 128(4): 804-814

MiR-145, a microRNA targeting ADAM17, inhibits the invasion and migration of nasopharyngeal carcinoma cells. Experimental Cell Research 338(2): 232-238

MiR-146 and miR-125 in the regulation of innate immunity and inflammation. Bmb Reports 49(6): 311-318

MiR-146a Regulates Inflammatory Infiltration by Macrophages in Polymyositis/Dermatomyositis by Targeting TRAF6 and Affecting IL-17/ICAM-1 Pathway. Cellular Physiology and Biochemistry 40(3-4): 486-498

MiR-146a activates WAVE2 expression and enhances phagocytosis in lipopolysaccharide-stimulated RAW264.7 macrophages. American Journal of Translational Research 7(8): 1467-1474

MiR-146a modulates macrophage polarization by inhibiting Notch1 pathway in RAW264.7 macrophages. International Immunopharmacology 32: 46-54

MiR-146a modulates macrophage polarization in systemic juvenile idiopathic arthritis by targeting INHBA. Molecular Immunology 77: 205-212

MiR-146a polymorphism correlates with lung cancer risk in Chinese nonsmoking females. Oncotarget (): -

MiR-146a rs2910164 polymorphism and head and neck carcinoma risk: a meta-analysis based on 10 case-control studies. Oncotarget (): -

MiR-146a rs2910164 polymorphism increases the risk of digestive system cancer: A meta-analysis. Clinics and Research in Hepatology and Gastroenterology (): -

MiR-146a rs2910164 polymorphism is associated with hepatocellular carcinoma: a meta-analysis. International Journal of Clinical and Experimental Medicine 8(9): 15852-6

MiR-146a suppresses hepatocellular carcinoma by downregulating TRAF6. American Journal of Cancer Research 6(11): 2502-2513

MiR-146a-5p inhibits cell proliferation and cell cycle progression in NSCLC cell lines by targeting CCND1 and CCND2. Oncotarget (): -

MiR-146b Mediates Endotoxin Tolerance in Human Phagocytes. Mediators of Inflammation 2015: 145305-145305

MiR-146b attenuates high-fat diet-induced non-alcoholic steatohepatitis in mice. Journal of Gastroenterology and Hepatology 30(5): 933-943

MiR-146b-5p overexpression attenuates stemness and radioresistance of glioma stem cells by targeting HuR/lincRNA-p21/β-catenin pathway. Oncotarget 7(27): 41505-41526

MiR-146b-5p promotes metastasis and induces epithelial-mesenchymal transition in thyroid cancer by targeting ZNRF3. Cellular Physiology and Biochemistry 35(1): 71-82

MiR-148a Functions as a Tumor Suppressor by Targeting CCK-BR via Inactivating STAT3 and Akt in Human Gastric Cancer. Plos One 11(8): E0158961-E0158961

MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer. Oncotarget 7(15): 20381-20394

MiR-148a participates in the growth of RPMI8226 multiple myeloma cells by regulating CDKN1B. Biomedicine & PharmacoTherapy 84(): 1967-1971

MiR-148a the epigenetic regulator of bone homeostasis is increased in plasma of osteoporotic postmenopausal women. Wiener Klinische Wochenschrift 128(Suppl 7): 519-526

MiR-148a, a microRNA upregulated in the WNT subgroup tumors, inhibits invasion and tumorigenic potential of medulloblastoma cells by targeting Neuropilin 1. Oncoscience 2(4): 334-348

MiR-150 Controls B Cell Differentiation by Targeting the Transcription Factor c-Myb. Cell 165(4): 1027-1027

MiR-150 Regulates Poststroke Cerebral Angiogenesis via Vascular Endothelial Growth Factor in Rats. Cns Neuroscience & Therapeutics 22(6): 507-517

MiR-150 impairs inflammatory cytokine production by targeting ARRB-2 after blocking CD28/B7 costimulatory pathway. Immunology Letters 172: 1-10

MiR-152 regulates metastases of non-small cell lung cancer cells by targeting neuropilin-1. International Journal of Clinical and Experimental Pathology 8(11): 14235-14240

MiR-153 as a Tumor Suppressor in Glioblastoma Multiforme is Downregulated by DNA Methylation. Clinical Laboratory 62(4): 573-580

MiR-153 inhibits epithelial-mesenchymal transition by targeting metadherin in human breast cancer. Breast Cancer Research and Treatment 150(3): 501-509

MiR-153 inhibits migration and invasion of human non-small-cell lung cancer by targeting ADAM19. Biochemical and Biophysical Research Communications 456(1): 385-391

MiR-153 promotes breast cancer cell apoptosis by targeting HECTD3. American Journal of Cancer Research 6(7): 1563-1571

MiR-153 regulates metastases of gastric cancer through Snail. Tumour Biology

MiR-153/Kv7.4: a novel molecular axis in the regulation of hypertension. Cardiovascular Research: -

MiR-154 Functions as a Tumor Suppressor in Glioblastoma by Targeting Wnt5a. Molecular Neurobiology (): -

MiR-154 directly suppresses DKK2 to activate Wnt signaling pathway and enhance activation of cardiac fibroblasts. Cell Biology International 40(12): 1271-1279

MiR-154-5p regulates osteogenic differentiation of adipose-derived mesenchymal stem cells under tensile stress through the Wnt/PCP pathway by targeting Wnt11. Bone 78: 130-141

MiR-155 Enhances Insulin Sensitivity by Coordinated Regulation of Multiple Genes in Mice. Plos Genetics 12(10): E1006308-E1006308

MiR-155 Knockout in Fibroblasts Improves Cardiac Remodeling by Targeting Tumor Protein p53-Inducible Nuclear Protein 1. Journal of Cardiovascular Pharmacology and Therapeutics 21(4): 423-435

MiR-155 and its functional variant rs767649 contribute to the susceptibility and survival of Hepatocellular carcinoma. Oncotarget (): -

MiR-155 expression level changes might be associated with initial phases of breast cancer pathogenesis and lymph-node metastasis. Cancer Biomarkers 16(3): 385-394

MiR-155 is upregulated in patients with active tuberculosis and inhibits apoptosis of monocytes by targeting FOXO3. Molecular Medicine Reports 12(5): 7102-7108

MiR-155 modulates the progression of neuropathic pain through targeting SGK3. International Journal of Clinical and Experimental Pathology 8(11): 14374-14382

MiR-155 promotes epithelial-mesenchymal transition in hepatocellular carcinoma cells through the activation of PI3K/SGK3/β-catenin signaling pathways. Oncotarget (): -

MiR-155 targets TP53INP1 to regulate liver cancer stem cell acquisition and self-renewal. Febs Letters 589(4): 500-506

MiR-155-regulated molecular network orchestrates cell fate in the innate and adaptive immune response to Mycobacterium tuberculosis. Proceedings of the National Academy of Sciences of the United States of America 113(41): E6172-E6181

MiR-15a and miR-16 induce autophagy and enhance chemosensitivity of Camptothecin. Cancer Biology & Therapy 16(6): 941-948

MiR-15a contributes abnormal immune response in myasthenia gravis by targeting CXCL10. Clinical Immunology 164: 106-113

MiR-15a-5p regulates viability and matrix degradation of human osteoarthritis chondrocytes via targeting VEGFA. Bioscience Trends (): -

MiR-15a/16 Regulates Apoptosis of Lung Epithelial Cells after Oxidative Stress. Molecular Medicine 22(): -

MiR-15a/16 regulates the growth of myeloma cells, angiogenesis and antitumor immunity by inhibiting Bcl-2, VEGF-A and IL-17 expression in multiple myeloma. Leukemia Research 49: 73-79

MiR-15b mediates liver cancer cells proliferation through targeting BCL-2. International Journal of Clinical and Experimental Pathology 8(12): 15677-15683

MiR-16 family as potential diagnostic biomarkers for cancer: a systematic review and meta-analysis. International Journal of Clinical and Experimental Medicine 8(2): 1703-1714

MiR-16 modulate temozolomide resistance by regulating BCL-2 in human glioma cells. International Journal of Clinical and Experimental Pathology 8(10): 12698-12707

MiR-16 regulates cell death in Alzheimer's disease by targeting amyloid precursor protein. European Review for Medical and Pharmacological Sciences 19(21): 4020-4027

MiR-16 regulates mouse peritoneal macrophage polarization and affects T-cell activation. Journal of Cellular and Molecular Medicine 20(10): 1898-1907

MiR-16 targets Bcl-2 in paclitaxel-resistant lung cancer cells and overexpression of miR-16 along with miR-17 causes unprecedented sensitivity by simultaneously modulating autophagy and apoptosis. Cellular Signalling 27(2): 189-203

MiR-17 Downregulation by High Glucose Stabilizes Thioredoxin-Interacting Protein and Removes Thioredoxin Inhibition on ASK1 Leading to Apoptosis. Toxicological Sciences 150(1): 84-96

MiR-17 Targets PTEN and Facilitates Glial Scar Formation after Spinal Cord Injuries via the PI3K/Akt/mTOR Pathway. Brain Research Bulletin (): -

MiR-17-5p as circulating biomarkers for the severity of coronary atherosclerosis in coronary artery disease. International Journal of Cardiology 197: 123-124

MiR-17-5p promotes cancer cell proliferation and tumorigenesis in nasopharyngeal carcinoma by targeting p21. Cancer Medicine 5(12): 3489-3499

MiR-17-5p regulates cell proliferation and migration by targeting transforming growth factor-β receptor 2 in gastric cancer. Oncotarget 7(22): 33286-33296

MiR-17-5p up-regulates YES1 to modulate the cell cycle progression and apoptosis in ovarian cancer cell lines. Journal of Cellular Biochemistry 116(6): 1050-1059

MiR-17-92 cluster promotes hepatocarcinogenesis. Carcinogenesis 36(10): 1213-1222

MiR-17-92 represses PTPROt and PP2A phosphatases and amplifies tonic BCR signaling in DLBCL cells. Experimental Hematology (): -

MiR-17~92 ablation impairs liver regeneration in an estrogen-dependent manner. Journal of Cellular and Molecular Medicine 20(5): 939-948

MiR-181a Promotes Proliferation of Human Acute Myeloid Leukemia Cells by Targeting ATM. Zhongguo Shi Yan Xue Ye Xue Za Zhi 24(2): 347-351

MiR-181a Targets PHLPP2 to Augment AKT Signaling and Regulate Proliferation and Apoptosis in Human Keloid Fibroblasts. Cellular Physiology and Biochemistry 40(3-4): 796-806

MiR-181a influences the cognitive function of epileptic rats induced by pentylenetetrazol. International Journal of Clinical and Experimental Pathology 8(10): 12861-8

MiR-181a suppresses autophagy and sensitizes gastric cancer cells to cisplatin. Gene 576(2 Pt 2): 828-833

MiR-181a upregulation is associated with epithelial-to-mesenchymal transition (EMT) and multidrug resistance (MDR) of ovarian cancer cells. European Review for Medical and Pharmacological Sciences 20(10): 2004-2010

MiR-181a-5p inhibits cell proliferation and migration by targeting Kras in non-small cell lung cancer A549 cells. Acta Biochimica et Biophysica Sinica 47(8): 630-638

MiR-181a-5p promotes anoikis by suppressing autophagy during detachment induction in the mammary epithelial cell line MCF10A. Protein & Cell 7(4): 305-309

MiR-181a-5p regulates 3T3-L1 cell adipogenesis by targeting Smad7 and Tcf7l2. Acta Biochimica et Biophysica Sinica 48(11): 1034-1041

MiR-181a: a potential biomarker of acute muscle wasting following elective high-risk cardiothoracic surgery. Critical Care 19(): 147-147

MiR-181b Antagonizes Atherosclerotic Plaque Vulnerability Through Modulating Macrophage Polarization by Directly Targeting Notch1. Molecular Neurobiology (): -

MiR-181b promotes chemoresistance in breast cancer by regulating Bim expression. Oncology Reports 35(2): 683-690

MiR-182 Is Associated with Growth, Migration and Invasion in Prostate Cancer via Suppression of FOXO1. Journal of Cancer 6(12): 1295-1305

MiR-182 promotes proliferation and invasion and elevates the HIF-1α-VEGF-A axis in breast cancer cells by targeting FBXW7. American Journal of Cancer Research 6(8): 1785-1798

MiR-183 Regulates ITGB1P Expression and Promotes Invasion of Endometrial Stromal Cells. Biomed Research International 2015: 340218-340218

MiR-183 functions as an oncogene by targeting ABCA1 in colon cancer. Oncology Reports 35(5): 2873-2879

MiR-183 modulates multi-drug resistance in hepatocellular cancer (HCC) cells via miR-183-IDH2/SOCS6-HIF-1α feedback loop. European Review for Medical and Pharmacological Sciences 20(10): 2020-2027

MiR-183 promotes growth of non-small cell lung cancer cells through FoxO1 inhibition. Tumour Biology 36(10): 8121-8126

MiR-184 Regulates Proliferation in Nucleus Pulposus Cells by Targeting GAS1. World Neurosurgery (): -

MiR-185 acts as a tumor suppressor by targeting AKT1 in non-small cell lung cancer cells. International Journal of Clinical and Experimental Pathology 8(9): 11854-11862

MiR-185 attenuates androgen receptor function in prostate cancer indirectly by targeting bromodomain containing 8 isoform 2, an androgen receptor co-activator. Molecular and Cellular Endocrinology 427(): 13-20

MiR-185 is involved in human breast carcinogenesis by targeting Vegfa. Febs Letters 588(23): 4438-4447

MiR-185-3p and miR-324-3p Predict Radiosensitivity of Nasopharyngeal Carcinoma and Modulate Cancer Cell Growth and Apoptosis by Targeting SMAD7. Medical Science Monitor 21: 2828-2836

MiR-185/AKT and miR-29a/Collagen 1a pathways are activated in IPF BAL cells. Oncotarget (): -

MiR-186 suppresses the growth and metastasis of bladder cancer by targeting NSBP1. Diagnostic Pathology 10(): 146-146

MiR-187 Targets the Androgen-Regulated Gene ALDH1A3 in Prostate Cancer. Plos One 10(5): E0125576-E0125576

MiR-18a Can Regulate Chemotherapy Sensitivity of Leukemia Cell HL-60 to VP-16 and VCR by Targeting ATM. Zhongguo Shi Yan Xue Ye Xue Za Zhi 23(4): 999-1004

MiR-18a increased the permeability of BTB via RUNX1 mediated down-regulation of ZO-1, occludin and claudin-5. Cellular Signalling 27(1): 156-167

MiR-18a upregulation decreases Dicer expression and confers paclitaxel resistance in triple negative breast cancer. European Review for Medical and Pharmacological Sciences 20(11): 2201-2208

MiR-18a upregulation enhances autophagy in triple negative cancer cells via inhibiting mTOR signaling pathway. European Review for Medical and Pharmacological Sciences 20(11): 2194-2200

MiR-18b suppresses high-glucose-induced proliferation in HRECs by targeting IGF-1/IGF1R signaling pathways. International Journal of Biochemistry & Cell Biology 73: 41-52

MiR-1908 promotes scar formation post-burn wound healing by suppressing Ski-mediated inflammation and fibroblast proliferation. Cell and Tissue Research 366(2): 371-380

MiR-190b, the highest up-regulated miRNA in ERα-positive compared to ERα-negative breast tumors, a new biomarker in breast cancers?. Bmc Cancer 15(): 499-499

MiR-191 Regulates Primary Human Fibroblast Proliferation and Directly Targets Multiple Oncogenes. Plos One 10(5): E0126535-E0126535

MiR-191 inhibits TNF-α induced apoptosis of ovarian endometriosis and endometrioid carcinoma cells by targeting DAPK1. International Journal of Clinical and Experimental Pathology 8(5): 4933-4942

MiR-191 modulates malignant transformation of endometriosis through regulating TIMP3. Medical Science Monitor 21(): 915-920

MiR-192 suppresses the tumorigenicity of prostate cancer cells by targeting and inhibiting nin one binding protein. International Journal of Molecular Medicine 37(2): 485-492

MiR-192-Mediated Positive Feedback Loop Controls the Robustness of Stress-Induced p53 Oscillations in Breast Cancer Cells. Plos Computational Biology 11(12): E1004653-E1004653

MiR-193a-3p and miR-193a-5p suppress the metastasis of human osteosarcoma cells by down-regulating Rab27B and SRR, respectively. Clinical & Experimental Metastasis 33(4): 359-372

MiR-193a-3p promotes the multi-chemoresistance of bladder cancer by targeting the HOXC9 gene. Cancer Letters 357(1): 105-113

MiR-193a-5p Targets the Coding Region of AP-2α mRNA and Induces Cisplatin Resistance in Bladder Cancers. Journal of Cancer 7(12): 1740-1746

MiR-193a-5p/ERBB2 act as concurrent chemoradiation therapy response indicator of esophageal squamous cell carcinoma. Oncotarget 7(26): 39680-39693

MiR-193b Mediates CEBPD-induced Cisplatin Sensitization Through Targeting ETS1 and Cyclin D1 in Human Urothelial Carcinoma Cells. Journal of Cellular Biochemistry (): -

MiR-193b promotes autophagy and non-apoptotic cell death in oesophageal cancer cells. Bmc Cancer 16(): 101-101

MiR-193b regulates early chondrogenesis by inhibiting the TGF-beta2 signaling pathway. Febs Letters 589(9): 1040-1047

MiR-194 inhibits cell proliferation and invasion via repression of RAP2B in bladder cancer. Biomedicine & PharmacoTherapy 80: 268-275

MiR-194, commonly repressed in colorectal cancer, suppresses tumor growth by regulating the MAP4K4/c-Jun/MDM2 signaling pathway. Cell Cycle 14(7): 1046-1058

MiR-195 Suppresses Cervical Cancer Migration and Invasion Through Targeting Smad3. International Journal of Gynecological Cancer 26(5): 817-824

MiR-195 dependent roles of mitofusin2 in the mitochondrial dysfunction of hippocampal neurons in SAMP8 mice. Brain Research 1652(): 135-143

MiR-195 enhances cardiomyocyte apoptosis induced by hypoxia/reoxygenation injury via downregulating c-myb. European Review for Medical and Pharmacological Sciences 20(16): 3410-3416

MiR-195 inhibits the proliferation of human cervical cancer cells by directly targeting cyclin D1. Tumour Biology 37(5): 6457-6463

MiR-195 is a key negative regulator of hepatocellular carcinoma metastasis by targeting FGF2 and VEGFA. International Journal of Clinical and Experimental Pathology 8(11): 14110-14120

MiR-195 participates in the placental disorder of preeclampsia via targeting activin receptor type-2B in trophoblastic cells. Journal of Hypertension 34(7): 1371-1379

MiR-195 suppresses non-small cell lung cancer by targeting CHEK1. Oncotarget 6(11): 9445-9456

MiR-196a Regulates High Glucose-Induced Mesangial Cell Hypertrophy by Targeting p27kip1. Journal of Laboratory Automation 20(4): 491-499

MiR-196a regulates heme oxygenase-1 by silencing Bach1 in the neonatal mouse lung. American Journal of Physiology. Lung Cellular and Molecular Physiology 311(2): L400-L411

MiR-196a2 rs11614913 T>C Polymorphism is Associated with an Increased Risk of Tetralogy of Fallot in a Chinese Population. Acta Cardiologica Sinica 31(1): 18-23

MiR-197 induces Taxol resistance in human ovarian cancer cells by regulating NLK. Tumour Biology 36(9): 6725-6732

MiR-199a inhibits the angiogenic potential of endometrial stromal cells under hypoxia by targeting HIF-1α/VEGF pathway. International Journal of Clinical and Experimental Pathology 8(5): 4735-4744

MiR-199a-3p promotes gastric cancer progression by targeting ZHX1. Febs Letters 588(23): 4504-4512

MiR-199a-5p and miR-375 affect colon cancer cell sensitivity to cetuximab by targeting PHLPP1. Expert Opinion on Therapeutic Targets 19(8): 1017-1026

MiR-199a-5p is negatively associated with malignancies and regulates glycolysis and lactate production by targeting hexokinase 2 in liver cancer. Hepatology 62(4): 1132-1144

MiR-199a/b-3p suppresses migration and invasion of breast cancer cells by downregulating PAK4/MEK/ERK signaling pathway. Iubmb Life 67(10): 768-777

MiR-199b-5p inhibits osteogenic differentiation in ligamentum flavum cells by targeting JAG1 and modulating the Notch signalling pathway. Journal of Cellular and Molecular Medicine (): -

MiR-19a overexpression contributes to heart failure through targeting ADRB1. International Journal of Clinical and Experimental Medicine 8(1): 642-649

MiR-19a promotes cell proliferation and invasion by targeting RhoB in human glioma cells. Neuroscience Letters 628: 161-166

MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer. World Journal of Gastroenterology 21(15): 4564-4573

MiR-19a targets suppressor of cytokine signaling 1 to modulate the progression of neuropathic pain. International Journal of Clinical and Experimental Pathology 8(9): 10901-7

MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells. Journal of Translational Medicine 14(1): 122-122

MiR-19b suppresses PTPRG to promote breast tumorigenesis. Oncotarget (): -

MiR-2 family regulates insect metamorphosis by controlling the juvenile hormone signaling pathway. Proceedings of the National Academy of Sciences of the United States of America 112(12): 3740-3745

MiR-2 family targets awd and fng to regulate wing morphogenesis in Bombyx mori. Rna Biology 12(7): 742-748

MiR-200 Regulates Epithelial-Mesenchymal Transition in Anaplastic Thyroid Cancer via EGF/EGFR Signaling. Cell Biochemistry and Biophysics 72(1): 185-190

MiR-200 modulates coelomocytes antibacterial activities and LPS priming via targeting Tollip in Apostichopus japonicus. Fish & Shellfish Immunology 45(2): 431-436

MiR-200 suppresses metastases of colorectal cancer through ZEB1. Tumour Biology

MiR-200a Suppresses the Proliferation and Metastasis in Pancreatic Ductal Adenocarcinoma through Downregulation of DEK Gene. Translational Oncology 9(1): 25-31

MiR-200b expression in breast cancer: a prognostic marker and act on cell proliferation and apoptosis by targeting Sp1. Journal of Cellular and Molecular Medicine 19(4): 760-769

MiR-200b modulates the properties of human monocyte-derived dendritic cells by targeting WASF3. Life Sciences 122(): 26-36

MiR-200b promotes the cell proliferation and metastasis of cervical cancer by inhibiting FOXG1. Biomedicine & PharmacoTherapy 79(): 294-301

MiR-200b regulates autophagy associated with chemoresistance in human lung adenocarcinoma. Oncotarget 6(32): 32805-32820

MiR-200b/200c/429 subfamily negatively regulates Rho/ROCK signaling pathway to suppress hepatocellular carcinoma metastasis. Oncotarget 6(15): 13658-13670

MiR-200c and miR-141 inhibit ZEB1 synergistically and suppress glioma cell growth and migration. European Review for Medical and Pharmacological Sciences 20(16): 3385-3391

MiR-200c promotes bladder cancer cell migration and invasion by directly targeting RECK. Oncotargets and Therapy 9(): 5091-5099

MiR-202 promotes endometriosis by regulating SOX6 expression. International Journal of Clinical and Experimental Medicine 8(10): 17757-17764

MiR-203 Determines Poor Outcome and Suppresses Tumor Growth by Targeting TBK1 in Osteosarcoma. Cellular Physiology and Biochemistry 37(5): 1956-1966

MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer. Journal of Experimental & Clinical Cancer Research 34(): 8-8

MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2. Oncotarget 6(11): 8914-8928

MiR-203 inhibits melanoma invasive and proliferative abilities by targeting the polycomb group gene BMI1. Biochemical and Biophysical Research Communications 456(1): 361-366

MiR-203 inhibits tumor invasion and metastasis in gastric cancer by ATM. Acta Biochimica et Biophysica Sinica 48(8): 696-703

MiR-203 promotes the growth and migration of ovarian cancer cells by enhancing glycolytic pathway. Tumour Biology 37(11): 14989-14997

MiR-203 sensitizes glioma cells to temozolomide and inhibits glioma cell invasion by targeting E2F3. Molecular Medicine Reports 11(4): 2838-2844

MiR-203 suppresses ZNF217 upregulation in colorectal cancer and its oncogenicity. Plos One 10(1): E0116170-E0116170

MiR-204 inhibits the proliferation and invasion of renal cell carcinoma by inhibiting RAB22A expression. Oncology Reports 35(5): 3000-3008

MiR-204 is responsible for inherited retinal dystrophy associated with ocular coloboma. Proceedings of the National Academy of Sciences of the United States of America 112(25): E3236-E3245

MiR-204 regulates HMGA2 expression and inhibits cell proliferation in human thyroid cancer. Cancer Biomarkers 15(5): 535-542

MiR-204 silencing in intraepithelial to invasive cutaneous squamous cell carcinoma progression. Molecular Cancer 15(1): 53-53

MiR-204, down-regulated in retinoblastoma, regulates proliferation and invasion of human retinoblastoma cells by targeting CyclinD2 and MMP-9. Febs Letters 589(5): 645-650

MiR-204-5p suppresses cell proliferation by inhibiting IGFBP5 in papillary thyroid carcinoma. Biochemical and Biophysical Research Communications 457(4): 621-626

MiR-204-5p/Six1 feedback loop promotes epithelial-mesenchymal transition in breast cancer. Tumour Biology 37(2): 2729-2735

MiR-205 and MiR-373 Are Associated with Aggressive Human Mucinous Colorectal Cancer. Plos One 11(6): E0156871-E0156871

MiR-205 and MiR-375 microRNA assays to distinguish squamous cell carcinoma from adenocarcinoma in lung cancer biopsies. Journal of Thoracic Oncology 10(3): 446-453

MiR-205 and miR-218 expression is associated with carboplatin chemoresistance and regulation of apoptosis via Mcl-1 and Survivin in lung cancer cells. Cellular Signalling 27(8): 1576-1588

MiR-205 functions as a tumor suppressor in adenocarcinoma and an oncogene in squamous cell carcinoma of esophagus. Tumour Biology 37(6): 8007-8018

MiR-205 functions as a tumor suppressor via targeting TGF-α in osteosarcoma. Experimental and Molecular Pathology 100(1): 160-166

MiR-205 promotes motility of ovarian cancer cells via targeting ZEB1. Gene 574(2): 330-336

MiR-205 promotes proliferation, migration and invasion of nasopharyngeal carcinoma cells by activation of AKT signalling. Journal of International Medical Research 44(2): 231-240

MiR-205 suppresses autophagy and enhances radiosensitivity of prostate cancer cells by targeting TP53INP1. European Review for Medical and Pharmacological Sciences 20(1): 92-100

MiR-206 Attenuates Denervation-Induced Skeletal Muscle Atrophy in Rats Through Regulation of Satellite Cell Differentiation via TGF-β1, Smad3, and HDAC4 Signaling. Medical Science Monitor 22: 1161-1170

MiR-206 controls the phenotypic modulation of pulmonary arterial smooth muscle cells induced by serum from rats with hepatopulmonary syndrome by regulating the target gene, annexin A2. Cellular Physiology and Biochemistry 34(5): 1768-1779

MiR-206 functions as a tumor suppressor and directly targets K-Ras in human oral squamous cell carcinoma [Retraction. Oncotargets and Therapy 9(): 6377-6377

MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway. Oncotarget 7(14): 18247-18261

MiR-206 is expressed in pancreatic islets and regulates glucokinase activity. American Journal of Physiology. Endocrinology and Metabolism 311(1): E175-E185

MiR-206 suppresses epithelial mesenchymal transition by targeting TGF-β signaling in estrogen receptor positive breast cancer cells. Oncotarget 7(17): 24537-24548

MiR-206, a Cerebellum Enriched miRNA Is Downregulated in All Medulloblastoma Subgroups and Its Overexpression Is Necessary for Growth Inhibition of Medulloblastoma Cells. Journal of Molecular Neuroscience 56(3): 673-680

MiR-206, a key modulator of skeletal muscle development and disease. International Journal of Biological Sciences 11(3): 345-352

MiR-207/352 regulate lysosomal-associated membrane proteins and enzymes following ischemic stroke. Neuroscience 305: 1-14

MiR-208a stimulates the cocktail of SOX2 and β-catenin to inhibit the let-7 induction of self-renewal repression of breast cancer stem cells and formed miR208a/let-7 feedback loop via LIN28 and DICER1. Oncotarget 6(32): 32944-32954

MiR-20a Induces Cell Radioresistance by Activating the PTEN/PI3K/Akt Signaling Pathway in Hepatocellular Carcinoma. International Journal of Radiation Oncology, Biology, Physics 92(5): 1132-1140

MiR-20a and miR-20b negatively regulate autophagy by targeting RB1CC1/FIP200 in breast cancer cells. Life Sciences 147(): 143-152

MiR-20a promotes cervical cancer proliferation and metastasis in vitro and in vivo. Plos One 10(3): E0120905-E0120905

MiR-20a regulates the PRKG1 gene by targeting its coding region in pulmonary arterial smooth muscle cells. Febs Letters 588(24): 4677-4685

MiR-20a-5p mediates hypoxia-induced autophagy by targeting ATG16L1 in ischemic kidney injury. Life Sciences 136(): 133-141

MiR-20a-5p represses multi-drug resistance in osteosarcoma by targeting the KIF26B gene. Cancer Cell International 16(): 64-64

MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway. Thyroid

MiR-20b targets AKT3 and modulates vascular endothelial growth factor-mediated changes in diabetic retinopathy. Acta Biochimica et Biophysica Sinica 48(8): 732-740

MiR-21 Protected Cardiomyocytes against Doxorubicin-Induced Apoptosis by Targeting BTG2. International Journal of Molecular Sciences 16(7): 14511-14525

MiR-21 alleviates secondary blood-brain barrier damage after traumatic brain injury in rats. Brain Research 1603: 150-157

MiR-21 and MiR-155 promote non-small cell lung cancer progression by downregulating SOCS1, SOCS6, and PTEN. Oncotarget (): -

MiR-21 and miR-183 can simultaneously target SOCS6 and modulate growth and invasion of hepatocellular carcinoma (HCC) cells. European Review for Medical and Pharmacological Sciences 19(17): 3208-3217

MiR-21 and miR-222 inhibit apoptosis of adult dorsal root ganglion neurons by repressing TIMP3 following sciatic nerve injury. Neuroscience Letters 586: 43-49

MiR-21 enhances melanoma invasiveness via inhibition of tissue inhibitor of metalloproteinases 3 expression: in vivo effects of MiR-21 inhibitor. Plos One 10(1): E0115919-E0115919

MiR-21 in Extracellular Vesicles Leads to Neurotoxicity via TLR7 Signaling in SIV Neurological Disease. Plos Pathogens 11(7): E1005032-E1005032

MiR-21 inhibitor suppressed the progression of retinoblastoma via the modulation of PTEN/PI3K/AKT pathway. Cell Biology International 40(12): 1294-1302

MiR-21 inhibits autophagy by targeting Rab11a in renal ischemia/reperfusion. Experimental Cell Research 338(1): 64-69

MiR-21 is involved in radiation-induced bystander effects. Rna Biology 11(9): 1161-1170

MiR-21 is required for efficient kidney regeneration in fish. Bmc Developmental Biology 15(): 43-43

MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway. Oncotarget 6(30): 28867-28881

MiR-21 modulates human airway smooth muscle cell proliferation and migration in asthma through regulation of PTEN expression. Experimental Lung Research 41(10): 535-545

MiR-21 modulates radiosensitivity of cervical cancer through inhibiting autophagy via the PTEN/Akt/HIF-1α feedback loop and the Akt-mTOR signaling pathway. Tumour Biology 37(9): 12161-12168

MiR-21 overexpression improves osteoporosis by targeting RECK. Molecular and Cellular Biochemistry 405(1-2): 125-133

MiR-21 promoted proliferation and migration in hepatocellular carcinoma through negative regulation of Navigator-3. Biochemical and Biophysical Research Communications 464(4): 1228-1234

MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN. Oncotarget 6(8): 5932-5946

MiR-21 suppresses endothelial progenitor cell proliferation by activating the TGFβ signaling pathway via downregulation of WWP1. International Journal of Clinical and Experimental Pathology 8(1): 414-422

MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma. Diagnostic Pathology 10(): 38-38

MiR-21-5p and miR-126a-3p levels in plasma and circulating angiogenic cells: relationship with type 2 diabetes complications. Oncotarget 6(34): 35372-35382

MiR-21/RASA1 axis affects malignancy of colon cancer cells via RAS pathways. World Journal of Gastroenterology 21(5): 1488-1497

MiR-21/miR-375 ratio is an independent prognostic factor in patients with laryngeal squamous cell carcinoma. American Journal of Cancer Research 5(5): 1775-1785

MiR-210 expression reverses radioresistance of stem-like cells of oesophageal squamous cell carcinoma. World Journal of Clinical Oncology 5(5): 1068-1077

MiR-210 links hypoxia with cell proliferation regulation in human Laryngocarcinoma cancer. Journal of Cellular Biochemistry 116(6): 1039-1049

MiR-210 promotes sensory hair cell formation in the organ of corti. Bmc Genomics 17(): 309-309

MiR-210 up-regulation inhibits proliferation and induces apoptosis in glioma cells by targeting SIN3A. Medical Science Monitor 20(): 2571-2577

MiR-211 inhibits cell proliferation and invasion of gastric cancer by down-regulating SOX4. International Journal of Clinical and Experimental Pathology 8(11): 14013-14020

MiR-211 inhibits invasion and epithelial-to-mesenchymal transition (EMT) of cervical cancer cells via targeting MUC4. Biochemical and Biophysical Research Communications (): -

MiR-211 is epigenetically regulated by DNMT1 mediated methylation and inhibits EMT of melanoma cells by targeting RAB22A. Biochemical and Biophysical Research Communications 476(4): 400-405

MiR-211 promotes invasion of hepatoma cells by targeting estrogen receptor alpha. Zhonghua Gan Zang Bing Za Zhi 23(7): 527-532

MiR-211/STAT5A Signaling Modulates Migration of Mesenchymal Stem Cells to Improve its Therapeutic Efficacy. Stem Cells 34(7): 1846-1858

MiR-212-3p inhibits LPS-induced inflammatory response through targeting HMGB1 in murine macrophages. Experimental Cell Research: -

MiR-212-3p inhibits glioblastoma cell proliferation by targeting SGK3. Journal of Neuro-Oncology 122(3): 431-439

MiR-212/132 is epigenetically downregulated by SOX4/EZH2-H3K27me3 feedback loop in ovarian cancer cells. Tumour Biology

MiR-214 Attenuates Osteogenic Differentiation of Mesenchymal Stem Cells via Targeting FGFR1. Cellular Physiology and Biochemistry 38(2): 809-820

MiR-214 increases the sensitivity of breast cancer cells to tamoxifen and fulvestrant through inhibition of autophagy. Molecular Cancer 14(): 208-208

MiR-214 regulates the pathogenesis of patients with coronary artery disease by targeting VEGF. Molecular and Cellular Biochemistry 402(1-2): 111-122

MiR-214 suppressed ovarian cancer and negatively regulated semaphorin 4D. Tumour Biology 37(6): 8239-8248

MiR-214-3p attenuates cognition defects via the inhibition of autophagy in SAMP8 mouse model of sporadic Alzheimer's disease. Neurotoxicology 56(): 139-149

MiR-215 Is Induced Post-transcriptionally via HIF-Drosha Complex and Mediates Glioma-Initiating Cell Adaptation to Hypoxia by Targeting KDM1B. Cancer Cell 29(1): 49-60

MiR-215, an activator of the CTNNBIP1/β-catenin pathway, is a marker of poor prognosis in human glioma. Oncotarget 6(28): 25024-25033

MiR-217 Promotes Tumor Proliferation in Breast Cancer via Targeting DACH1. Journal of Cancer 6(2): 184-191

MiR-217 is down-regulated in psoriasis and promotes keratinocyte differentiation via targeting GRHL2. Biochemical and Biophysical Research Communications 471(1): 169-176

MiR-217 mediates the protective effects of the dopamine D2 receptor on fibrosis in human renal proximal tubule cells. Hypertension 65(5): 1118-1125

MiR-218 Inhibited Growth and Metabolism of Human Glioblastoma Cells by Directly Targeting E2F2. Cellular and Molecular Neurobiology 35(8): 1165-1173

MiR-218 Inhibits Erythroid Differentiation and Alters Iron Metabolism by Targeting ALAS2 in K562 Cells. International Journal of Molecular Sciences 16(12): 28156-28168

MiR-218 impedes IL-6-induced prostate cancer cell proliferation and invasion via suppression of LGR4 expression. Oncology Reports 35(5): 2859-2865

MiR-218 inhibits HMGB1-mediated autophagy in endometrial carcinoma cells during chemotherapy. International Journal of Clinical and Experimental Pathology 8(6): 6617-6626

MiR-218 inhibits multidrug resistance (MDR) of gastric cancer cells by targeting Hedgehog/smoothened. International Journal of Clinical and Experimental Pathology 8(6): 6397-6406

MiR-218 inhibits the tumorgenesis and proliferation of glioma cells by targeting Robo1. Cancer Biomarkers 16(3): 309-317

MiR-218 mediates tumorigenesis and metastasis: Perspectives and implications. Experimental Cell Research 334(1): 173-182

MiR-218-5p inhibits the stem cell properties and invasive ability of the A2B5⁺CD133⁻ subgroup of human glioma stem cells. Oncology Reports 35(2): 869-877

MiR-21: an environmental driver of malignant melanoma?. Journal of Translational Medicine 13: 202-202

MiR-21a-5p suppresses bisphenol A-induced pre-adipocyte differentiation by targeting map2k3 through MKK3/p38/MAPK. Biochemical and Biophysical Research Communications 473(1): 140-146

MiR-22 Suppresses BMP7 in the Development of Cirrhosis. Cellular Physiology and Biochemistry 36(3): 1026-1036

MiR-22 promotes porcine reproductive and respiratory syndrome virus replication by targeting the host factor HO-1. Veterinary Microbiology 192: 226-230

MiR-22 regulates 5-FU sensitivity by inhibiting autophagy and promoting apoptosis in colorectal cancer cells. Cancer Letters 356(2 Pt B): 781-790

MiR-22-silenced cyclin A expression in colon and liver cancer cells is regulated by bile acid receptor. Journal of Biological Chemistry 290(10): 6507-6515

MiR-22/Sp-1 Links Estrogens With the Up-Regulation of Cystathionine γ-Lyase in Myocardium, Which Contributes to Estrogenic Cardioprotection Against Oxidative Stress. Endocrinology 156(6): 2124-2137

MiR-221 Exacerbate Cell Proliferation and Invasion by Targeting TIMP3 in Papillary Thyroid Carcinoma. American Journal of Therapeutics (): -

MiR-221 Promotes Capan-2 Pancreatic Ductal Adenocarcinoma Cells Proliferation by Targeting PTEN-Akt. Cellular Physiology and Biochemistry 38(6): 2366-2374

MiR-221 activates the NF-κB pathway by targeting A20. Biochemical and Biophysical Research Communications 472(1): 11-18

MiR-221 and miR-222 simultaneously target ARID1A and enhance proliferation and invasion of cervical cancer cells. European Review for Medical and Pharmacological Sciences 20(8): 1509-1515

MiR-221 and miR-26b Regulate Chemotactic Migration of MSCs Toward HGF Through Activation of Akt and FAK. Journal of Cellular Biochemistry 117(6): 1370-1383

MiR-221 as a pre- and postoperative plasma biomarker for larynx cancer patients. Laryngoscope 125(12): E377-E381

MiR-221 increases osteosarcoma cell proliferation, invasion and migration partly through the downregulation of PTEN. International Journal of Molecular Medicine 36(5): 1377-1383

MiR-221 promotes IgE-mediated activation of mast cells degranulation by PI3K/Akt/PLCγ/Ca(2+) pathway. Journal of Bioenergetics and Biomembranes 48(3): 293-299

MiR-221 promotes stemness of breast cancer cells by targeting DNMT3b. Oncotarget 7(1): 580-592

MiR-221-induced PUMA silencing mediates immune evasion of bladder cancer cells. International Journal of Oncology 46(3): 1169-1180

MiR-221-inhibited adipose tissue-derived mesenchymal stem cells bioengineered in a nano-hydroxy apatite scaffold. In Vitro Cellular & Developmental Biology. Animal 52(4): 479-487

MiR-221/222 promote human glioma cell invasion and angiogenesis by targeting TIMP2. Tumour Biology 36(5): 3763-3773

MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway. Gene 596(): 110-118

MiR-222 targeted PUMA to improve sensitization of UM1 cells to cisplatin. International Journal of Molecular Sciences 15(12): 22128-22141

MiR-223 inhibited cell metastasis of human cervical cancer by modulating epithelial-mesenchymal transition. International Journal of Clinical and Experimental Pathology 8(9): 11224-9

MiR-223 promotes the cisplatin resistance of human gastric cancer cells via regulating cell cycle by targeting FBXW7. Journal of Experimental & Clinical Cancer Research 34(): 28-28

MiR-223 suppresses endometrial carcinoma cells proliferation by targeting IGF-1R. American Journal of Translational Research 6(6): 841-849

MiR-223 targeting MAFB suppresses proliferation and migration of nasopharyngeal carcinoma cells. Bmc Cancer 15(): 461-461

MiR-223-3p as a Novel MicroRNA Regulator of Expression of Voltage-Gated K+ Channel Kv4.2 in Acute Myocardial Infarction. Cellular Physiology and Biochemistry 39(1): 102-114

MiR-223-5p works as an oncomiR in vulvar carcinoma by TP63 suppression. Oncotarget (): -

MiR-23a Regulates the Vasculogenesis of Coronary Artery Disease by Targeting Epidermal Growth Factor Receptor. Cardiovascular Therapeutics 34(4): 199-208

MiR-23a facilitates the replication of HSV-1 through the suppression of interferon regulatory factor 1. Plos One 9(12): E114021-E114021

MiR-23a inhibited IL-17-mediated proinflammatory mediators expression via targeting IKKα in articular chondrocytes. International Immunopharmacology 43(): 1-6

MiR-23a sensitizes nasopharyngeal carcinoma to irradiation by targeting IL-8/Stat3 pathway. Oncotarget 6(29): 28341-28356

MiR-23a-depressed autophagy is a participant in PUVA- and UVB-induced premature senescence. Oncotarget 7(25): 37420-37435

MiR-23b and miR-199a impair epithelial-to-mesenchymal transition during atrioventricular endocardial cushion formation. Developmental Dynamics 244(10): 1259-1275

MiR-23b controls TGF-β1 induced airway smooth muscle cell proliferation via TGFβR2/p-Smad3 signals. Molecular Immunology 70(): 84-93

MiR-23b targets cyclin G1 and suppresses ovarian cancer tumorigenesis and progression. Journal of Experimental & Clinical Cancer Research 35(): 31-31

MiR-24 enhances radiosensitivity in nasopharyngeal carcinoma by targeting SP1. Cancer Medicine 5(6): 1163-1173

MiR-24 functions as a tumor suppressor in nasopharyngeal carcinoma through targeting FSCN1. Journal of Experimental & Clinical Cancer Research 34(): 130-130

MiR-24 is required for hematopoietic differentiation of mouse embryonic stem cells. Plos Genetics 11(1): E1004959-E1004959

MiR-24-3p enhances cell growth in hepatocellular carcinoma by targeting metallothionein 1M. Cell Biochemistry and Function 34(7): 491-496

MiR-25 is up-regulated in non-small cell lung cancer and promotes cell proliferation and motility by targeting FBXW7. International Journal of Clinical and Experimental Pathology 8(8): 9147-9153

MiR-25 promotes hepatocellular carcinoma cell growth, migration and invasion by inhibiting RhoGDI1. Oncotarget 6(34): 36231-36244

MiR-25 protects cardiomyocytes against oxidative damage by targeting the mitochondrial calcium uniporter. International Journal of Molecular Sciences 16(3): 5420-5433

MiR-25 suppresses 3T3-L1 adipogenesis by directly targeting KLF4 and C/EBPα. Journal of Cellular Biochemistry 116(11): 2658-2666

MiR-26 down-regulates TNF-α/NF-κB signalling and IL-6 expression by silencing HMGA1 and MALT1. Nucleic Acids Research 44(8): 3772-3787

MiR-26a and miR-138 block the G1/S transition by targeting the cell cycle regulating network in prostate cancer cells. Journal of Cancer Research and Clinical Oncology 142(11): 2249-2261

MiR-26a and miR-144 inhibit proliferation and metastasis of esophageal squamous cell cancer by inhibiting cyclooxygenase-2. Oncotarget 7(12): 15173-15186

MiR-26a enhances autophagy to protect against ethanol-induced acute liver injury. Journal of Molecular Medicine 93(9): 1045-1055

MiR-26a enhances the sensitivity of gastric cancer cells to cisplatin by targeting NRAS and E2F2. Saudi Journal of Gastroenterology 21(5): 313-319

MiR-26a inhibits proliferation and migration of HaCaT keratinocytes through regulating PTEN expression. Gene 594(1): 117-124

MiR-26a modulates extracellular matrix homeostasis in cartilage. Matrix Biology 43: 27-34

MiR-26b inhibits autophagy by targeting ULK2 in prostate cancer cells. Biochemical and Biophysical Research Communications 472(1): 194-200

MiR-26b inhibits hepatocellular carcinoma cell proliferation, migration, and invasion by targeting EphA2. International Journal of Clinical and Experimental Pathology 8(5): 4782-4790

MiR-26b inhibits melanoma cell proliferation and enhances apoptosis by suppressing TRAF5-mediated MAPK activation. Biochemical and Biophysical Research Communications 471(3): 361-367

MiR-26b suppresses cell proliferation and invasion by targeting cyclooxygenase 2 in human glioblastoma. Oncotarget (): -

MiR-26b suppresses tumor cell proliferation, migration and invasion by directly targeting COX-2 in lung cancer. European Review for Medical and Pharmacological Sciences 19(24): 4728-4737

MiR-26b/KPNA2 axis inhibits epithelial ovarian carcinoma proliferation and metastasis through downregulating OCT4. Oncotarget 6(27): 23793-23806

MiR-27a ameliorates inflammatory damage to the blood-spinal cord barrier after spinal cord ischemia: reperfusion injury in rats by downregulating TICAM-2 of the TLR4 signaling pathway. Journal of Neuroinflammation 12(): 25-25

MiR-27a is Essential for the Shift from Osteogenic Differentiation to Adipogenic Differentiation of Mesenchymal Stem Cells in Postmenopausal Osteoporosis. Cellular Physiology and Biochemistry 39(1): 253-265

MiR-27a modulates radiosensitivity of triple-negative breast cancer (TNBC) cells by targeting CDC27. Medical Science Monitor 21(): 1297-1303

MiR-27a promotes hepatocellular carcinoma cell proliferation through suppression of its target gene peroxisome proliferator-activated receptor γ. Chinese Medical Journal 128(7): 941-947

MiR-27a regulates Wnt/beta-catenin signaling through targeting SFRP1 in glioma. Neuroreport 26(12): 695-702

MiR-27a-3p functions as an oncogene in gastric cancer by targeting BTG2. Oncotarget (): -

MiR-27a-3p promotes esophageal cancer cell proliferation via F-box and WD repeat domain-containing 7 (FBXW7) suppression. International Journal of Clinical and Experimental Medicine 8(9): 15556-15562

MiR-27b is epigenetically downregulated in tamoxifen resistant breast cancer cells due to promoter methylation and regulates tamoxifen sensitivity by targeting HMGB3. Biochemical and Biophysical Research Communications 477(4): 768-773

MiR-28 inhibits cardiomyocyte survival through suppressing PDK1/Akt/mTOR signaling. In Vitro Cellular & Developmental Biology. Animal 52(10): 1020-1025

MiR-28-3p as a potential plasma marker in diagnosis of pulmonary embolism. Thrombosis Research 138(): 91-95

MiR-285 targets P450 (CYP6N23) to regulate pyrethroid resistance in Culex pipiens pallens. Parasitology Research 115(12): 4511-4517

MiR-29 Induces K562 Cell Apoptosis by Down-Regulating FoxM1. Medical Science Monitor 21(): 3115-3120

MiR-29 mediates TGFβ 1-induced extracellular matrix synthesis through activation of Wnt/β -catenin pathway in human pulmonary fibroblasts. Technology and Health Care 23 Suppl 1(): S119-S125

MiR-29-mediated elastin down-regulation contributes to inorganic phosphorus-induced osteoblastic differentiation in vascular smooth muscle cells. Genes to Cells 20(12): 1077-1087

MiR-29/Hsp47 in ECM network. Oncoscience 2(10): 843-844

MiR-29a Regulates Radiosensitivity in Human Intestinal Cells by Targeting PTEN Gene. Radiation Research 186(3): 292-301

MiR-29a and MiR-140 Protect Chondrocytes against the Anti-Proliferation and Cell Matrix Signaling Changes by IL-1β. Molecules and Cells 39(2): 103-110

MiR-29a is a candidate biomarker of better survival in metastatic high-grade serous carcinoma. Human Pathology 54: 74-81

MiR-29a promotes cell proliferation and EMT in breast cancer by targeting ten eleven translocation 1. Biochimica et Biophysica Acta 1862(11): 2177-2185

MiR-29a promotes intestinal epithelial apoptosis in ulcerative colitis by down-regulating Mcl-1. International Journal of Clinical and Experimental Pathology 7(12): 8542-8552

MiR-29a reduces TIMP-1 production by dermal fibroblasts via targeting TGF-β activated kinase 1 binding protein 1, implications for systemic sclerosis. Plos One 9(12): E115596-E115596

MiR-29a suppresses prostate cell proliferation and induces apoptosis via KDM5B protein regulation. International Journal of Clinical and Experimental Medicine 8(4): 5329-5339

MiR-29b suppresses the proliferation and migration of osteosarcoma cells by targeting CDK6. Protein & Cell 7(6): 434-444

MiR-29c downregulation contributes to metastatic progression in colorectal cancer. Annals of Oncology 26(10): 2199-2200

MiR-29c inhibits cell growth, invasion, and migration of pancreatic cancer by targeting ITGB1. Oncotargets and Therapy 9: 99-109

MiR-29c regulates the expression of miR-34c and miR-449a by targeting DNA methyltransferase 3a and 3b in nasopharyngeal carcinoma. Bmc Cancer 16(): 218-218

MiR-300 regulate the malignancy of breast cancer by targeting p53. International Journal of Clinical and Experimental Medicine 8(5): 6957-6966

MiR-300 suppresses laryngeal squamous cell carcinoma proliferation and metastasis by targeting ROS1. American Journal of Translational Research 8(9): 3903-3911

MiR-301a is activated by the Wnt/β-catenin pathway and promotes glioma cell invasion by suppressing SEPT7. Neuro-Oncology 18(9): 1288-1296

MiR-301a is involved in adipocyte dysfunction during obesity-related inflammation via suppression of PPARγ. Die Pharmazie 71(2): 84-88

MiR-301a mediates the effect of IL-6 on the AKT/GSK pathway and hepatic glycogenesis by regulating PTEN expression. Cellular Physiology and Biochemistry 35(4): 1413-1424

MiR-301a promotes cell proliferation by directly targeting TIMP2 in multiple myeloma. International Journal of Clinical and Experimental Pathology 8(8): 9168-9174

MiR-301a promotes colorectal cancer cell growth and invasion by directly targeting SOCS6. Cellular Physiology and Biochemistry 35(1): 227-236

MiR-301a regulates E-cadherin expression and is predictive of prostate cancer recurrence. Prostate 76(10): 869-884

MiR-302/367 regulate neural progenitor proliferation, differentiation timing, and survival in neurulation. Developmental Biology 408(1): 140-150

MiR-302a inhibits the tumorigenicity of ovarian cancer cells by suppression of SDC1. International Journal of Clinical and Experimental Pathology 8(5): 4869-4880

MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1). Journal of Experimental & Clinical Cancer Research 35(): 25-25

MiR-302c-3p suppresses invasion and proliferation of glioma cells via down-regulating metadherin (MTDH) expression. Cancer Biology & Therapy 16(9): 1308-1315

MiR-3099 is Overexpressed in Differentiating 46c Mouse Embryonic Stem Cells upon Neural Induction. Malaysian Journal of Medical Sciences 21(Spec Issue): 27-33

MiR-30a Decreases Multidrug Resistance (MDR) of Gastric Cancer Cells. Medical Science Monitor 0(): 0-0

MiR-30a Inhibits the Epithelial--Mesenchymal Transition of Podocytes through Downregulation of NFATc3. International Journal of Molecular Sciences 16(10): 24032-24047

MiR-30a and miR-205 are downregulated in hypoxia and modulate radiosensitivity of prostate cancer cells by inhibiting autophagy via TP53INP1. European Review for Medical and Pharmacological Sciences 20(8): 1501-1508

MiR-30a attenuates immunosuppressive functions of IL-1β-elicited mesenchymal stem cells via targeting TAB3. Febs Letters 589(24 Pt B): 3899-3907

MiR-30a increases cisplatin sensitivity of gastric cancer cells through suppressing epithelial-to-mesenchymal transition (EMT). European Review for Medical and Pharmacological Sciences 20(9): 1733-1739

MiR-30a inhibits Th17 differentiation and demyelination of EAE mice by targeting the IL-21R. Brain, Behavior, and Immunity 57: 193-199

MiR-30a regulates the atrial fibrillation-induced myocardial fibrosis by targeting snail 1. International Journal of Clinical and Experimental Pathology 8(12): 15527-15536

MiR-30a regulates the proliferation, migration, and invasion of human osteosarcoma by targeting Runx2. Tumour Biology 37(3): 3479-3488

MiR-30a suppresses non-small cell lung cancer progression through AKT signaling pathway by targeting IGF1R. Cellular and Molecular Biology 61(2): 78-85

MiR-30a upregulates BCL2A1, IER3 and cyclin D2 expression by targeting FOXL2. Oncology Letters 9(2): 967-971

MiR-30a-5p Overexpression May Overcome EGFR-Inhibitor Resistance through Regulating PI3K/AKT Signaling Pathway in Non-small Cell Lung Cancer Cell Lines. Frontiers in Genetics 7(): 197-197

MiR-30a-5p Suppresses Tumor Metastasis of Human Colorectal Cancer by Targeting ITGB3. Cellular Physiology and Biochemistry 39(3): 1165-1176

MiR-30a-5p is induced by Wnt/β-catenin pathway and promotes glioma cell invasion by repressing NCAM. Biochemical and Biophysical Research Communications 465(3): 374-380

MiR-30a-5p suppresses cell growth and enhances apoptosis of hepatocellular carcinoma cells via targeting AEG-1. International Journal of Clinical and Experimental Pathology 8(12): 15632-15641

MiR-30a-5p/UBE3C axis regulates breast cancer cell proliferation and migration. Biochemical and Biophysical Research Communications (): -

MiR-30b Is Involved in the Homocysteine-Induced Apoptosis in Human Coronary Artery Endothelial Cells by Regulating the Expression of Caspase 3. International Journal of Molecular Sciences 16(8): 17682-17695

MiR-30b suppresses tumor migration and invasion by targeting EIF5A2 in gastric cancer. World Journal of Gastroenterology 21(31): 9337-9347

MiR-30c-2* negative regulated MTA-1 expression involved in metastasis and drug resistance of HPV-infected non-small cell lung cancer. Surgery 160(6): 1591-1598

MiR-30e suppresses proliferation of hepatoma cells via targeting prolyl 4-hydroxylase subunit alpha-1 (P4HA1) mRNA. Biochemical and Biophysical Research Communications 472(3): 516-522

MiR-30s Family Inhibit the Proliferation and Apoptosis in Human Coronary Artery Endothelial Cells Through Targeting the 3'UTR Region of ITGA4 and PLCG1. Journal of Cardiovascular Pharmacology 68(5): 327-333

MiR-31 Downregulation Protects Against Cardiac Ischemia/Reperfusion Injury by Targeting Protein Kinase C Epsilon (PKCε) Directly. Cellular Physiology and Biochemistry 36(1): 179-190

MiR-31 Functions as a Tumor Suppressor in Lung Adenocarcinoma Mainly by Targeting HuR. Clinical Laboratory 62(4): 711-718

MiR-31 Regulates Rho-Associated Kinase-Myosin Light Chain (ROCK-MLC) Pathway and Inhibits Gastric Cancer Invasion: Roles of RhoA. Medical Science Monitor 22(): 4679-4691

MiR-31 and miR-128 regulates poliovirus receptor-related 4 mediated measles virus infectivity in tumors. Molecular Oncology 10(9): 1387-1403

MiR-31 inhibits migration and invasion by targeting SATB2 in triple negative breast cancer. Gene 594(1): 47-58

MiR-31 modulates coelomocytes ROS production via targeting p105 in Vibrio splendidus challenged sea cucumber Apostichopus japonicus in vitro and in vivo. Fish & Shellfish Immunology 45(2): 293-299

MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer. Oncotarget (): -

MiR-31/SDHA Axis Regulates Reprogramming Efficiency through Mitochondrial Metabolism. Stem Cell Reports 7(1): 1-10

MiR-3162-3p Is a Novel MicroRNA That Exacerbates Asthma by Regulating β-Catenin. Plos One 11(3): E0149257-E0149257

MiR-32 contributed to cell proliferation of human breast cancer cells by suppressing of PHLPP2 expression. Biomedicine & PharmacoTherapy 75: 105-110

MiR-32 functions as a tumor suppressor and directly targets EZH2 in human oral squamous cell carcinoma. Medical Science Monitor 20(): 2527-2535

MiR-32 induces cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting PTEN. Tumour Biology 36(6): 4747-4755

MiR-32 promotes gastric carcinoma tumorigenesis by targeting Kruppel-like factor 4. Biochemical and Biophysical Research Communications 467(4): 913-920

MiR-320a acts as a prognostic factor and Inhibits metastasis of salivary adenoid cystic carcinoma by targeting ITGB3. Molecular Cancer 14(): 96-96

MiR-320a contributes to atherogenesis by augmenting multiple risk factors and down-regulating SRF. Journal of Cellular and Molecular Medicine 19(5): 970-985

MiR-320a inhibits gastric carcinoma by targeting activity in the FoxM1-P27KIP1 axis. Oncotarget 7(20): 29275-29286

MiR-323 Inhibits Prostate Cancer Vascularization Through Adiponectin Receptor. Cellular Physiology and Biochemistry 36(4): 1491-1498

MiR-323-5p acts as a tumor suppressor by targeting the insulin-like growth factor 1 receptor in human glioma cells. Asian Pacific Journal of Cancer Prevention 15(23): 10181-5

MiR-324-5p Suppresses Hepatocellular Carcinoma Cell Invasion by Counteracting ECM Degradation through Post-Transcriptionally Downregulating ETS1 and SP1. Plos One 10(7): E0133074-E0133074

MiR-326 inhibits gastric cancer cell growth through down regulating NOB1. Oncology Research (): -

MiR-326 is a diagnostic biomarker and regulates cell survival and apoptosis by targeting Bcl-2 in osteosarcoma. Biomedicine & PharmacoTherapy 84(): 828-835

MiR-326 regulates cell proliferation and migration in lung cancer by targeting phox2a and is regulated by HOTAIR. American Journal of Cancer Research 6(2): 173-186

MiR-328 suppresses the survival of esophageal cancer cells by targeting PLCE1. Biochemical and Biophysical Research Communications 470(1): 175-180

MiR-328 targeting PIM-1 inhibits proliferation and migration of pulmonary arterial smooth muscle cells in PDGFBB signaling pathway. Oncotarget (): -

MiR-329 suppresses osteosarcoma development by downregulating Rab10. Febs Letters 590(17): 2973-2981

MiR-330-3p inhibits gastric cancer progression through targeting MSI1. American Journal of Translational Research 8(11): 4802-4811

MiR-330-5p regulates tyrosinase and PDIA3 expression and suppresses cell proliferation and invasion in cutaneous malignant melanoma. Journal of Surgical Research 203(2): 434-440

MiR-331-3p inhibits proliferation and promotes apoptosis by targeting HER2 through the PI3K/Akt and ERK1/2 pathways in colorectal cancer. Oncology Reports 35(2): 1075-1082

MiR-335 Regulates Hif-1α to Reduce Cell Death in Both Mouse Cell Line and Rat Ischemic Models. Plos One 10(6): E0128432-E0128432

MiR-335 acts as a potential tumor suppressor miRNA via downregulating ROCK1 expression in hepatocellular carcinoma. Tumour Biology 36(8): 6313-6319

MiR-335 functions as a tumor suppressor and regulates survivin expression in osteosarcoma. European Review for Medical and Pharmacological Sciences 20(7): 1251-1257

MiR-335 inhibits migration of breast cancer cells through targeting oncoprotein c-Met. Tumour Biology 36(4): 2875-2883

MiR-335 is involved in major depression disorder and antidepressant treatment through targeting GRM4. Neuroscience Letters 606: 167-172

MiR-335 regulates the chemo-radioresistance of small cell lung cancer cells by targeting PARP-1. Gene (): -

MiR-338* suppresses fibrotic pathogenesis in pulmonary fibrosis through targeting LPA1. American Journal of Translational Research 8(7): 3197-3205

MiR-338* targeting smoothened to inhibit pulmonary fibrosis by epithelial-mesenchymal transition. American Journal of Translational Research 8(7): 3206-3213

MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signaling. Oncotarget 6(17): 15222-15234

MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α. Plos One 9(12): E115565-E115565

MiR-338-3p inhibits the proliferation and migration of gastric cancer cells by targeting ADAM17. International Journal of Clinical and Experimental Pathology 8(9): 10922-8

MiR-338-3p targets pyruvate kinase M2 and affects cell proliferation and metabolism of ovarian cancer. American Journal of Translational Research 8(7): 3266-3273

MiR-338-5p sensitizes glioblastoma cells to radiation through regulation of genes involved in DNA damage response. Tumour Biology 37(6): 7719-7727

MiR-339 and especially miR-766 reactivate the expression of tumor suppressor genes in colorectal cancer cell lines through DNA methyltransferase 3B gene inhibition. Cancer Biology & Therapy 17(11): 1126-1138

MiR-33a Decreases High-Density Lipoprotein-Induced Radiation Sensitivity in Breast Cancer. International Journal of Radiation Oncology, Biology, Physics 95(2): 791-799

MiR-33a suppresses breast cancer cell proliferation and metastasis by targeting ADAM9 and ROS1. Protein & Cell 6(12): 881-889

MiR-33a suppresses proliferation of NSCLC cells via targeting METTL3 mRNA. Biochemical and Biophysical Research Communications (): -

MiR-340 Regulates Fibrinolysis and Axon Regrowth Following Sciatic Nerve Injury. Molecular Neurobiology (): -

MiR-340 impedes the progression of laryngeal squamous cell carcinoma by targeting EZH2. Gene 577(2): 193-201

MiR-340 suppresses cell migration and invasion by targeting MYO10 in breast cancer. Oncology Reports 35(2): 709-716

MiR-345 suppresses proliferation, migration and invasion by targeting Smad1 in human prostate cancer. Journal of Cancer Research and Clinical Oncology 142(1): 213-224

MiR-346 promotes the biological function of breast cancer cells by targeting SRCIN1 and reduces chemosensitivity to docetaxel. Gene (): -

MiR-346 regulates CD4⁺CXCR5⁺ T cells in the pathogenesis of Graves' disease. Endocrine 49(3): 752-760

MiR-34a Inhibits Breast Cancer Proliferation and Progression by Targeting Wnt1 in Wnt/β-Catenin Signaling Pathway. American Journal of the Medical Sciences 352(2): 191-199

MiR-34a Inhibits Viability and Invasion of Human Papillomavirus-Positive Cervical Cancer Cells by Targeting E2F3 and Regulating Survivin. International Journal of Gynecological Cancer 25(4): 707-713

MiR-34a Promotes Osteogenic Differentiation of Human Adipose-Derived Stem Cells via the RBP2/NOTCH1/CYCLIN D1 Coregulatory Network. Stem Cell Reports 7(2): 236-248

MiR-34a and miR-203 Inhibit Survivin Expression to Control Cell Proliferation and Survival in Human Osteosarcoma Cells. Journal of Cancer 7(9): 1057-1065

MiR-34a inhibits colon cancer proliferation and metastasis by inhibiting platelet-derived growth factor receptor α. Molecular Medicine Reports 12(5): 7072-7078

MiR-34a inhibits migration and invasion by regulating the SIRT1/p53 pathway in human SW480 cells. Molecular Medicine Reports 11(5): 3301-3307

MiR-34a inhibits oral cancer progression partially by repression of interleukin-6-receptor. International Journal of Clinical and Experimental Pathology 8(2): 1364-1373

MiR-34a is Involved in the Decrease of ATP Contents Induced by Resistin Through Target on ATP5S in HepG2 Cells. Biochemical Genetics 53(11-12): 301-309

MiR-34a modulates ErbB2 in breast cancer. Cell Biology International 41(1): 93-101

MiR-34a promotes Fas-mediated cartilage endplate chondrocyte apoptosis by targeting Bcl-2. Molecular and Cellular Biochemistry 406(1-2): 21-30

MiR-34a regulates blood-brain barrier permeability and mitochondrial function by targeting cytochrome c. Journal of Cerebral Blood Flow and Metabolism 36(2): 387-392

MiR-34a regulates blood-tumor barrier function by targeting protein kinase Cε. Molecular Biology of the Cell 26(10): 1786-1796

MiR-34a suppresses amphiregulin and tumor metastatic potential of head and neck squamous cell carcinoma (HNSCC). Oncotarget 6(10): 7454-7469

MiR-34a suppresses ovarian cancer proliferation and motility by targeting AXL. Tumour Biology 36(9): 7277-7283

MiR-34a, a promising novel biomarker for benzene toxicity, is involved in cell apoptosis triggered by 1,4-benzoquinone through targeting Bcl-2. Environmental Pollution (): -

MiR-34a-5p promotes the multi-drug resistance of osteosarcoma by targeting the CD117 gene. Oncotarget 7(19): 28420-28434

MiR-34b-3 and miR-449a inhibit malignant progression of nasopharyngeal carcinoma by targeting lactate dehydrogenase A. Oncotarget (): -

MiR-34b/c rs4938723 Polymorphism Significantly Decreases the Risk of Digestive Tract Cancer: Meta-analysis. Asian Pacific Journal of Cancer Prevention 16(14): 6099-6104

MiR-34c-3p suppresses the proliferation and invasion of non-small cell lung cancer (NSCLC) by inhibiting PAC1/MAPK pathway. International Journal of Clinical and Experimental Pathology 8(6): 6312-6322

MiR-361-5p inhibits colorectal and gastric cancer growth and metastasis by targeting staphylococcal nuclease domain containing-1. Oncotarget 6(19): 17404-17416

MiR-362-5p promotes the malignancy of chronic myelocytic leukaemia via down-regulation of GADD45α. Molecular Cancer 14(): 190-190

MiR-363-3p inhibits the epithelial-to-mesenchymal transition and suppresses metastasis in colorectal cancer by targeting Sox4. Biochemical and Biophysical Research Communications 474(1): 35-42

MiR-367 negatively regulates apoptosis induced by adriamycin in osteosarcoma cells by targeting KLF4. Journal of Bone Oncology 5(2): 51-56

MiR-370 promotes cell death of liver cancer cells by Akt/FoxO3a signalling pathway. European Review for Medical and Pharmacological Sciences 20(10): 2011-2019

MiR-371-373 cluster acts as a tumor-suppressor-miR and promotes cell cycle arrest in unrestricted somatic stem cells. Tumour Biology 36(10): 7765-7774

MiR-373 drives the epithelial-to-mesenchymal transition and metastasis via the miR-373-TXNIP-HIF1α-TWIST signaling axis in breast cancer. Oncotarget 6(32): 32701-32712

MiR-373 targeting of the Rab22a oncogene suppresses tumor invasion and metastasis in ovarian cancer. Oncotarget 5(23): 12291-12303

MiR-373-3p Promotes Invasion and Metastasis of Lung Adenocarcinoma Cells. Zhongguo Fei Ai Za Zhi 18(7): 427-435

MiR-374a promotes the proliferation of human osteosarcoma by downregulating FOXO1 expression. International Journal of Clinical and Experimental Medicine 8(3): 3482-3489

MiR-374a promotes the proliferation of osteosarcoma cell proliferation by targeting Axin2. International Journal of Clinical and Experimental Pathology 8(9): 10776-10783

MiR-374a suppresses lung adenocarcinoma cell proliferation and invasion by targeting TGFA gene expression. Carcinogenesis 37(6): 567-575

MiR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis. World Journal of Gastroenterology 20(46): 17439-17447

MiR-375 Is Epigenetically Downregulated by HPV-16 E6 Mediated DNMT1 Upregulation and Modulates EMT of Cervical Cancer Cells by Suppressing lncRNA MALAT1. Plos One 11(9): E0163460-E0163460

MiR-375 Mediates CRH Signaling Pathway in Inhibiting E2 Synthesis in Porcine Ovary. Reproduction (): -

MiR-375 and miR-200c as predictive biomarkers of islet isolation and transplantation in total pancreatectomy with islet autotransplantation. Journal of Hepato-Biliary-Pancreatic Sciences 23(9): 585-594

MiR-375 is Essential for Human Spinal Motor Neuron Development and May Be Involved in Motor Neuron Degeneration. Stem Cells 34(1): 124-134

MiR-375 is epigenetically downregulated due to promoter methylation and modulates multi-drug resistance in breast cancer cells via targeting YBX1. European Review for Medical and Pharmacological Sciences 20(15): 3223-3229

MiR-375 promotes redifferentiation of adult human β cells expanded in vitro. Plos One 10(4): E0122108-E0122108

MiR-375 targets KLF4 and impacts the proliferation of colorectal carcinoma. Tumour Biology 37(1): 463-471

MiR-376a and histone deacetylation 9 form a regulatory circuitry in hepatocellular carcinoma. Cellular Physiology and Biochemistry 35(2): 729-739

MiR-377 inhibits the proliferation of pancreatic cancer by targeting Pim-3. Tumour Biology 37(11): 14813-14824

MiR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma. Molecular Cancer 14(): 68-68

MiR-378 Plays an Important Role in the Differentiation of Bovine Preadipocytes. Cellular Physiology and Biochemistry 36(4): 1552-1562

MiR-378 promotes the migration of liver cancer cells by down-regulating Fus expression. Cellular Physiology and Biochemistry 34(6): 2266-2274

MiR-378 suppresses prostate cancer cell growth through downregulation of MAPK1 in vitro and in vivo. Tumour Biology 37(2): 2095-2103

MiR-378a-3p enhances adipogenesis by targeting mitogen-activated protein kinase 1. Biochemical and Biophysical Research Communications 457(1): 37-42

MiR-378b Promotes Differentiation of Keratinocytes through NKX3.1. Plos One 10(8): E0136049-E0136049

MiR-381 functions as a tumor suppressor in colorectal cancer by targeting Twist1. Oncotargets and Therapy 9: 1231-1239

MiR-381 inhibits epithelial ovarian cancer malignancy via YY1 suppression. Tumour Biology 37(7): 9157-9167

MiR-381-3p Regulates the Antigen-Presenting Capability of Dendritic Cells and Represses Antituberculosis Cellular Immune Responses by Targeting CD1c. Journal of Immunology 197(2): 580-589

MiR-382 inhibits cell growth and invasion by targeting NR2F2 in colorectal cancer. Molecular Carcinogenesis 55(12): 2260-2267

MiR-383 inhibits proliferation, migration and angiogenesis of glioma-exposed endothelial cells in vitro via VEGF-mediated FAK and Src signaling pathways. Cellular Signalling 30(): 142-153

MiR-384 inhibits human colorectal cancer metastasis by targeting KRAS and CDC42. Oncotarget (): -

MiR-384 regulated IRS1 expression and suppressed cell proliferation of human hepatocellular carcinoma. Tumour Biology 37(10): 14165-14171

MiR-410 Down-Regulates the Expression of Interleukin-10 by Targeting STAT3 in the Pathogenesis of Systemic Lupus Erythematosus. Cellular Physiology and Biochemistry 39(1): 303-315

MiR-422a acts as a tumor suppressor in glioblastoma by targeting PIK3CA. American Journal of Cancer Research 6(8): 1695-1707

MiR-422a promotes loco-regional recurrence by targeting NT5E/CD73 in head and neck squamous cell carcinoma. Oncotarget 7(28): 44023-44038

MiR-423-3p enhances cell growth through inhibition of p21Cip1/Waf1 in colorectal cancer. Cellular Physiology and Biochemistry 37(3): 1044-1054

MiR-424 and miR-27a increase TRAIL sensitivity of acute myeloid leukemia by targeting PLAG1. Oncotarget 7(18): 25276-25290

MiR-424-5p participates in esophageal squamous cell carcinoma invasion and metastasis via SMAD7 pathway mediated EMT. Diagnostic Pathology 11(1): 88-88

MiR-4262 promotes proliferation and invasion of human breast cancer cells through directly targeting KLF6 and KLF15. Oncology Research (): -

MiR-4282 suppresses proliferation and mobility of human colorectal carcinoma cells by targeting semaphorin 3E. Panminerva Medica 58(3): 197-205

MiR-429 Induces Gastric Carcinoma Cell Apoptosis Through Bcl-2. Cellular Physiology and Biochemistry 37(4): 1572-1580

MiR-429 increases the metastatic capability of HCC via regulating classic Wnt pathway rather than epithelial-mesenchymal transition. Cancer Letters 364(1): 33-43

MiR-429 induces apoptosis of glioblastoma cell through Bcl-2. Tumour Biology

MiR-429 inhibits oral squamous cell carcinoma growth by targeting ZEB1. Medical Science Monitor 21(): 383-389

MiR-429 is linked to metastasis and poor prognosis in renal cell carcinoma by affecting epithelial-mesenchymal transition. Tumour Biology 37(11): 14653-14658

MiR-429 regulates gastric cancer cell invasiveness through ZEB proteins. Tumour Biology

MiR-429 reverses epithelial-mesenchymal transition by restoring E-cadherin expression in bladder cancer. Oncotarget 7(18): 26593-26603

MiR-4295 promotes cell growth in bladder cancer by targeting BTG1. American Journal of Translational Research 8(11): 4892-4901

MiR-433 inhibits retinoblastoma malignancy by suppressing Notch1 and PAX6 expression. Biomedicine & PharmacoTherapy 82: 247-255

MiR-433-3p suppresses cell growth and enhances chemosensitivity by targeting CREB in human glioma. Oncotarget (): -

MiR-448 promotes glycolytic metabolism of gastric cancer by downregulating KDM2B. Oncotarget 7(16): 22092-22102

MiR-449a Affects Epithelial Proliferation during the Pseudoglandular and Canalicular Phases of Avian and Mammal Lung Development. Plos One 11(2): E0149425-E0149425

MiR-449a exerts tumor-suppressive functions in human glioblastoma by targeting Myc-associated zinc-finger protein. Molecular Oncology 9(3): 640-656

MiR-449a promotes breast cancer progression by targeting CRIP2. Oncotarget 7(14): 18906-18918

MiR-449a regulates autophagy to inhibit silica-induced pulmonary fibrosis through targeting Bcl2. Journal of Molecular Medicine 94(11): 1267-1279

MiR-449a suppresses cell invasion by inhibiting MAP2K1 in non-small cell lung cancer. American Journal of Cancer Research 5(9): 2730-2744

MiR-449a suppresses the epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by multiple targets. Bmc Cancer 15(): 706-706

MiR-449c inhibits gastric carcinoma growth. Life Sciences 137(): 14-19

MiR-4500 is epigenetically downregulated in colorectal cancer and functions as a novel tumor suppressor by regulating HMGA2. Cancer Biology & Therapy 17(11): 1149-1157

MiR-451 inhibits proliferation of esophageal carcinoma cell line EC9706 by targeting CDKN2D and MAP3K1. World Journal of Gastroenterology 21(19): 5867-5876

MiR-451 inhibits synovial fibroblasts proliferation and inflammatory cytokines secretion in rheumatoid arthritis through mediating p38MAPK signaling pathway. International Journal of Clinical and Experimental Pathology 8(11): 14562-7

MiR-451, a potential prognostic biomarker and tumor suppressor for gastric cancer. International Journal of Clinical and Experimental Pathology 8(8): 9154-9160

MiR-454 inhibited cell proliferation of human glioblastoma cells by suppressing PDK1 expression. Biomedicine & PharmacoTherapy 75: 148-152

MiR-454 promotes the progression of human non-small cell lung cancer and directly targets PTEN. Biomedicine & PharmacoTherapy 81(): 79-85

MiR-454 prompts cell proliferation of human colorectal cancer cells by repressing CYLD expression. Asian Pacific Journal of Cancer Prevention 16(6): 2397-2402

MiR-455-3p regulates early chondrogenic differentiation via inhibiting Runx2. Febs Letters 589(23): 3671-3678

MiR-455-5p acts as a novel tumor suppressor in gastric cancer by down-regulating RAB18. Gene 592(2): 308-315

MiR-4638-5p inhibits castration resistance of prostate cancer through repressing Kidins220 expression and PI3K/AKT pathway activity. Oncotarget 7(30): 47444-47464

MiR-4653-3p and its target gene FRS2 are prognostic biomarkers for hormone receptor positive breast cancer patients receiving tamoxifen as adjuvant endocrine therapy. Oncotarget (): -

MiR-467a is upregulated in radiation-induced mouse thymic lymphomas and regulates apoptosis by targeting Fas and Bax. International Journal of Biological Sciences 11(1): 109-121

MiR-4728-3p could act as a marker of HER2 status. Cancer Biomarkers 15(6): 807-814

MiR-485 inhibits metastasis and EMT of lung adenocarcinoma by targeting Flot2. Biochemical and Biophysical Research Communications 477(4): 521-526

MiR-486 and miR-92a Identified in Circulating HDL Discriminate between Stable and Vulnerable Coronary Artery Disease Patients. Plos One 10(10): E0140958-E0140958

MiR-486 regulates cholesterol efflux by targeting HAT1. Biochemical and Biophysical Research Communications 472(3): 418-424

MiR-486 regulates lactation and targets the PTEN gene in cow mammary glands. Plos One 10(3): E0118284-E0118284

MiR-486-3p targeting ECM1 represses cell proliferation and metastasis in cervical cancer. Biomedicine & PharmacoTherapy 80: 109-114

MiR-487a Promotes TGF-β1-induced EMT, the Migration and Invasion of Breast Cancer Cells by Directly Targeting MAGI2. International Journal of Biological Sciences 12(4): 397-408

MiR-491 attenuates cancer stem cells-like properties of hepatocellular carcinoma by inhibition of GIT-1/NF-κB-mediated EMT. Tumour Biology 37(1): 201-209

MiR-492 is functionally involved in Oxaliplatin resistance in colon cancer cells LS174T via its regulating the expression of CD147. Molecular and Cellular Biochemistry 405(1-2): 73-79

MiR-493 suppresses the proliferation and invasion of gastric cancer cells by targeting RhoC. Iranian Journal of Basic Medical Sciences 18(10): 1027-1033

MiR-494 Inhibits Epithelial Ovarian Cancer Growth by Targeting c-Myc. Medical Science Monitor 22: 617-624

MiR-494-3p induced by compressive force inhibits cell proliferation in MC3T3-E1 cells. Journal of Bioscience and Bioengineering 120(4): 456-462

MiR-495 functions as an adjuvant to radiation therapy by reducing the radiation-induced bystander effect. Acta Biochimica et Biophysica Sinica 48(11): 1026-1033

MiR-495 inhibits esophageal squamous cell carcinoma progression by targeting Akt1. Oncotarget (): -

MiR-495 is a Predictive Biomarker that Downregulates GFI1 Expression in Medulloblastoma. Cellular Physiology and Biochemistry 36(4): 1430-1439

MiR-497 Suppresses YAP1 and Inhibits Tumor Growth in Non-Small Cell Lung Cancer. Cellular Physiology and Biochemistry 37(1): 342-352

MiR-497 decreases cisplatin resistance in ovarian cancer cells by targeting mTOR/P70S6K1. Oncotarget 6(28): 26457-26471

MiR-497 enhances metastasis of oral squamous cell carcinoma through SMAD7 suppression. American Journal of Translational Research 8(7): 3023-3031

MiR-497 promotes metastasis of colorectal cancer cells through Nrdp1 inhibition. Tumour Biology 36(10): 7641-7647

MiR-497 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting VEGFA and AEG-1. Oncotarget 6(30): 29527-29542

MiR-498 regulated FOXO3 expression and inhibited the proliferation of human ovarian cancer cells. Biomedicine & PharmacoTherapy 72: 52-57

MiR-499 Enhances the Cisplatin Sensitivity of Esophageal Carcinoma Cell Lines by Targeting DNA Polymerase β. Cellular Physiology and Biochemistry 36(4): 1587-1596